ALPHA & OMEGA SEMICONDUCTOR LTD, 10-K filed on 8/29/2023
Annual Report
v3.23.2
Cover - USD ($)
$ in Millions
12 Months Ended
Jun. 30, 2023
Jul. 31, 2023
Dec. 31, 2022
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Jun. 30, 2023    
Current Fiscal Year End Date --06-30    
Document Transition Report false    
Entity File Number 001-34717    
Entity Registrant Name Alpha and Omega Semiconductor Limited    
Entity Incorporation, State or Country Code D0    
Entity Tax Identification Number 77-0553536    
Entity Address, Address Line One Clarendon House    
Entity Address, Address Line Two 2 Church Street    
Entity Address, City or Town Hamilton    
Entity Address, Postal Zip Code HM 11    
Entity Address, Country BM    
City Area Code 408    
Local Phone Number 830-9742    
Title of 12(b) Security Common Shares, $0.002 par value per share    
Trading Symbol AOSL    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 654
Entity Common Stock, Shares Outstanding (in shares)   27,655,826  
Entity Central Index Key 0001387467    
Document Fiscal Year Focus 2023    
Document Fiscal Period Focus FY    
Amendment Flag false    
ICFR Auditor Attestation Flag false    
v3.23.2
Audit Information
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Audit Information [Abstract]    
Auditor Firm ID 23 243
Auditor Name Baker Tilly US, LLP BDO USA, LLP
Auditor Location Mountain View, California San Jose, California
v3.23.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2023
Jun. 30, 2022
Current assets:    
Cash and cash equivalents $ 195,188 $ 314,352
Restricted cash 415 299
Accounts receivable, net 22,420 65,681
Inventories 183,247 158,040
Other current assets 22,666 11,220
Total current assets 423,936 549,592
Property, plant and equipment, net 357,831 318,666
Operating lease right-of-use assets, net 24,349 23,674
Intangible assets, net 6,765 10,050
Equity method investment 366,617 378,378
Deferred income tax assets 536 592
Restricted cash - long-term 0 0
Other long-term assets 19,703 17,677
Total assets 1,199,737 1,298,629
Current liabilities:    
Accrued liabilities 79,533 116,893
Income taxes payable 5,546 4,248
Short-term debt 11,434 25,563
Deferred revenue 8,073 0
Finance lease liabilities 867 802
Operating lease liabilities 4,383 3,850
Total current liabilities 172,561 267,722
Long-term debt 38,360 42,486
Income taxes payable - long-term 2,817 2,158
Deferred income tax liabilities 27,283 28,757
Finance lease liabilities - long-term 3,216 3,932
Operating lease liabilities - long-term 20,544 20,878
Other long-term liabilities 51,037 78,603
Total liabilities 315,818 444,536
Commitments and contingencies (Note 15)
Preferred shares, par value $0.002 per share:    
Authorized: 10,000 shares; issued and outstanding: none at June 30, 2023 and 2022 0 0
Common shares, par value $0.002 per share:    
Authorized: 100,000 shares; issued and outstanding: 34,811 shares and 27,654 shares, respectively at June 30, 2023 and 33,988 shares and 27,371 shares, respectively at June 30, 2022 70 68
Treasury shares at cost; 7,157 shares at June 30, 2023 and 6,617 shares at June 30, 2022 (79,365) (66,000)
Additional paid-in capital 329,034 288,951
Accumulated other comprehensive income (loss) (8,111) 1,080
Retained earnings 642,291 629,994
Total Alpha and Omega Semiconductor Limited shareholders’ equity 883,919 854,093
Total liabilities and equity 1,199,737 1,298,629
Non-related Party    
Current liabilities:    
Accounts payable 50,775 87,377
Related Party    
Current liabilities:    
Accounts payable $ 11,950 $ 28,989
v3.23.2
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Jun. 30, 2023
Jun. 30, 2022
Preferred stock, par value (in dollars per share) $ 0.002 $ 0.002
Preferred stock, shares authorized (in shares) 10,000,000 10,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common shares, par value (in dollars per share) $ 0.002 $ 0.002
Common shares, authorized (in shares) 100,000,000 100,000,000
Common stock, shares issued (in shares) 34,811,000 33,988,000
Common stock, shares outstanding (in shares) 27,654,000 27,371,000
Treasury shares (in shares) 7,157,000 6,617,000
v3.23.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Income Statement [Abstract]      
Revenue $ 691,321 $ 777,552 $ 656,902
Operating expenses 491,785 508,996 452,359
Gross profit 199,536 268,556 204,543
Operating expenses:      
Research and development 88,146 71,259 62,953
Selling, general and administrative 88,861 95,259 77,514
Total operating expenses 177,007 166,518 140,467
Operating income 22,529 102,038 64,076
Interest expense, net (1,730) 999 2,456
Interest expense, net (1,087) (3,920) (6,308)
Gain on deconsolidation of the JV Company 0 399,093 0
Loss on changes of equity interest in the JV Company, net 0 (3,140) 0
Net income before income taxes 19,712 495,070 60,224
Income tax expense 5,937 39,258 3,935
Net income before loss from equity method investment 13,775 455,812 56,289
Equity method investment loss from equity investee (1,411) (2,629) 0
Net income 12,364 453,183 56,289
Net income (loss) attributable to noncontrolling interest 0 20 (1,827)
Net income attributable to Alpha and Omega Semiconductor Limited $ 12,364 $ 453,163 $ 58,116
Net income per common share attributable to Alpha and Omega Semiconductor Limited      
Basic (in dollars per share) $ 0.45 $ 16.93 $ 2.25
Diluted (in dollars per share) $ 0.42 $ 16.07 $ 2.13
Weighted average number of common share attributable to Alpha and Omega Semiconductor Limited used to compute net income per share:      
Basic (in shares) 27,552 26,764 25,786
Diluted (in shares) 29,528 28,203 27,272
v3.23.2
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Statement of Comprehensive Income [Abstract]      
Net income before loss from equity method investment $ 12,364 $ 453,183 $ 56,289
Foreign currency translation adjustment (9,191) 1,307 14,190
Cumulative translation adjustment removal due to deconsolidation of the JV Company 0 (3,642) 0
Comprehensive income 3,173 450,848 70,479
Less: Noncontrolling interest 0 (1,080) 4,921
Comprehensive income attributable to Alpha and Omega Semiconductor Limited $ 3,173 $ 451,928 $ 65,558
v3.23.2
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Total AOS Shareholders' Equity
Preferred Shares
Common Shares
Treasury Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (loss)
Retained Earnings
Noncontrolling Interest
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Balance $ 431,888                
Balance (in shares) at Jun. 30, 2020     0            
Balance (in shares) at Jun. 30, 2020       31,944,000          
Balance (in shares) at Jun. 30, 2020         (6,639,000)        
Balance at Jun. 30, 2020   $ 293,689 $ 0 $ 64 $ (66,184) $ 246,103 $ (5,127) $ 118,833 $ 138,199
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of common stock options and release of RSUs (in shares)       857,000          
Exercise of common stock options and release of RSUs 1,699 1,699   $ 1   1,698      
Reissuance of Treasury Stock (in shares)         14,000        
Reissuance of Treasury Stock 66 66     $ 120     (54)  
Withholding tax on restricted stock units (in shares)       (225,000)          
Withholding tax on restricted stock units (6,924) (6,924)       (6,924)      
Issuance of common shares under Employee Stock Purchase Plan (in shares)       399,000          
Issuance of common shares under Employee Stock Purchase Plan $ 3,327 3,327   $ 1   3,326      
Repurchase of common shares under share repurchase program (in shares) 0                
Share-based compensation expense $ 12,190 12,190       12,190      
Net income (loss) attributable to AOS 58,116 58,116           58,116  
Cumulative translation adjustment   7,442         7,442    
Net income (loss) attributable to noncontrolling interest (1,827)               (1,827)
Restricted stock units settlement in connection with service 3,600 3,600       3,600      
Foreign currency translation adjustment                 6,748
Foreign currency translation adjustment 14,190                
Net income before loss from equity method investment 56,289                
Balance (in shares) at Jun. 30, 2021     0            
Balance (in shares) at Jun. 30, 2021       32,975,000          
Balance (in shares) at Jun. 30, 2021         (6,625,000)        
Balance at Jun. 30, 2021   373,205 $ 0 $ 66 $ (66,064) 259,993 2,315 176,895 143,120
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Balance 516,325                
Exercise of common stock options and release of RSUs (in shares)       652,000          
Exercise of common stock options and release of RSUs 898 898   $ 1   897      
Reissuance of Treasury Stock (in shares)         8,000        
Reissuance of Treasury Stock 0 0     $ 64     (64)  
Withholding tax on restricted stock units (in shares)       (183,000)          
Withholding tax on restricted stock units (8,641) (8,641)       (8,641)      
Issuance of common shares under Employee Stock Purchase Plan (in shares)       544,000          
Issuance of common shares under Employee Stock Purchase Plan $ 5,245 5,245   $ 1   5,244      
Repurchase of common shares under share repurchase program (in shares) 0                
Share-based compensation expense $ 31,058 31,058       31,058      
Net income (loss) attributable to AOS 453,163 453,163           453,163  
Cumulative translation adjustment   558         558    
Net income (loss) attributable to noncontrolling interest 20               20
Restricted stock units settlement in connection with service 400 400       400      
Foreign currency translation adjustment                 749
Foreign currency translation adjustment 1,307                
Deconsolidation of noncontrolling interest (145,682) (1,793)         (1,793)   (143,889)
Net income before loss from equity method investment $ 453,183                
Balance (in shares) at Jun. 30, 2022 0   0            
Balance (in shares) at Jun. 30, 2022 33,988,000     33,988,000          
Balance (in shares) at Jun. 30, 2022 (6,617,000)       (6,617,000)        
Balance at Jun. 30, 2022 $ 854,093 854,093 $ 0 $ 68 $ (66,000) 288,951 1,080 629,994 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Balance 854,093                
Exercise of common stock options and release of RSUs (in shares)       715,000          
Exercise of common stock options and release of RSUs 551 551   $ 1   550      
Reissuance of Treasury Stock (in shares)         8,000        
Reissuance of Treasury Stock 0 0     $ 67     (67)  
Withholding tax on restricted stock units (in shares)       (242,000)          
Withholding tax on restricted stock units (6,381) (6,381)       (6,381)      
Issuance of common shares under Employee Stock Purchase Plan (in shares)       350,000          
Issuance of common shares under Employee Stock Purchase Plan 8,427 8,427   $ 1   8,426      
Repurchase of common shares under share repurchase program $ (13,432) (13,432)     $ (13,432)        
Repurchase of common shares under share repurchase program (in shares) (548,132)       (548,000)        
Share-based compensation expense $ 37,488 37,488       37,488      
Net income (loss) attributable to AOS 12,364 12,364           12,364  
Cumulative translation adjustment   (9,191)         (9,191)    
Net income (loss) attributable to noncontrolling interest 0                
Foreign currency translation adjustment (9,191)                
Net income before loss from equity method investment $ 12,364                
Balance (in shares) at Jun. 30, 2023 0   0            
Balance (in shares) at Jun. 30, 2023 34,811,000     34,811,000          
Balance (in shares) at Jun. 30, 2023 (7,157,000)       (7,157,000)        
Balance at Jun. 30, 2023 $ 883,919 $ 883,919 $ 0 $ 70 $ (79,365) $ 329,034 $ (8,111) $ 642,291 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Balance $ 883,919                
v3.23.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities      
Net income before loss from equity method investment $ 12,364 $ 453,183 $ 56,289
Adjustments to reconcile net income to net cash provided by operating activities:      
Gain on deconsolidation of the JV Company 0 (399,093) 0
Loss on changes of equity interest in the JV Company, net 0 3,140 0
Deferred income tax on deconsolidation and changes of equity interest in the JV Company 0 29,973 0
Depreciation and amortization 43,207 42,851 52,685
Equity method investment loss from equity investee 1,411 2,629 0
Share-based compensation expense 37,488 31,324 15,324
Deferred income taxes, net (1,418) 1,592 1,551
Loss on disposal of property and equipment 182 18 426
Changes in assets and liabilities:      
Accounts receivable 43,262 (30,085) (22,517)
Inventories (25,207) (57,416) (18,765)
Other current and long-term assets (18,695) (9,408) (5,843)
Payable related to equity investee, net (17,038) 48,192 0
Accounts payable (19,568) 23,755 (528)
Income taxes payable 1,957 (1,687) 1,660
Income taxes payable on deconsolidation and changes of equity interest in the JV Company 0 3,490 0
Increase in deferred revenue 8,073 0 0
Accrued and other liabilities (45,545) 76,407 48,462
Net cash provided by operating activities 20,473 218,865 128,744
Cash flows from investing activities      
Proceeds from sale of equity interest in the JV Company 0 26,347 0
Deconsolidation of cash and cash equivalents of the JV Company 0 (20,734) 0
Purchases of property and equipment (110,428) (138,014) (72,700)
Proceeds from sale of property and equipment 167 135 42
Government grant related to equipment 631 1,444 119
Net cash used in investing activities (109,630) (130,822) (72,539)
Cash flows from financing activities      
Withholding tax on restricted stock units (6,381) (8,641) (6,924)
Proceeds from exercise of stock options and ESPP 8,978 6,143 5,092
Payments for repurchase of common shares (13,432) 0 0
Proceeds from borrowings 8,632 64,276 65,876
Repayments of borrowings (26,598) (35,748) (66,584)
Principal payments on capital leases (810) (4,176) (16,451)
Net cash provided by (used in) financing activities (29,611) 21,854 (18,991)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (280) (59) 4,895
Net increase (decrease) in cash, cash equivalents and restricted cash (119,048) 109,838 42,109
Cash, cash equivalents and restricted cash at beginning of year 314,651 204,813 162,704
Cash, cash equivalents and restricted cash at end of year 195,603 314,651 204,813
Supplemental disclosures of cash flow information:      
Cash paid for interest 3,711 3,404 5,641
Cash paid for income taxes 1,537 5,768 970
Supplemental disclosures of non-cash investing and financing information:      
Property and equipment purchased but not yet paid 12,715 62,165 20,204
Reissuance of treasury stock 67 64 120
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]      
Cash and cash equivalents 195,188 314,352 202,412
Restricted cash 415 299 233
Restricted cash - long-term 0 0 2,168
Total cash, cash equivalents, and restricted cash $ 195,603 $ 314,651 $ 204,813
v3.23.2
The Company and Significant Accounting Policies
12 Months Ended
Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
The Company and Significant Accounting Policies The Company and Significant Accounting Policies
The Company

Alpha and Omega Semiconductor Limited and its subsidiaries (the “Company”, “AOS”, “we” or “us”) design, develop and supply a broad range of power semiconductors. The Company's portfolio of products targets high-volume applications, including personal computers, graphic cards, flat panel TVs, home appliances, smart phones, battery packs, quick chargers, home appliances, consumer and industrial motor controls and power supplies for TVs, computers, servers and telecommunications equipment. The Company conducts its operations primarily in the United States of America (“USA”), Hong Kong, China, and South Korea.
Basis of Preparation

The consolidated financial statements include the accounts of the Company, its wholly-owned subsidiaries and a subsidiary in which it had a controlling interest until December 1, 2021. As of December 2, 2021, the Company ceased having control over this subsidiary. Therefore, the Company deconsolidated this subsidiary as of that date. Subsequently, the Company has accounted for it using the equity method of accounting. All intercompany account balances and transactions have been eliminated. The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”).
Joint Venture

On March 29, 2016, the Company entered into a joint venture contract (the “JV Agreement”) with two investment funds owned by the Municipality of Chongqing (the “Chongqing Funds”), pursuant to which the Company and the Chongqing Funds formed a joint venture, (the “JV Company”), for the purpose of constructing and operating a power semiconductor packaging, testing and 12-inch wafer fabrication facility in the Liangjiang New Area of Chongqing, China (the “JV Transaction”). As of December 1, 2021, the Company owned 50.9%, and the Chongqing Funds owned 49.1%, of the equity interest in the JV Company. The Joint Venture was accounted under the provisions of the consolidation guidance since the Company had controlling financial interest until December 1, 2021. As of December 2, 2021, the Company ceased having control over the JV Company. Therefore, the Company deconsolidated the JV Company as of that date. Subsequently, the Company has accounted for its investment in the JV Company using the equity method of accounting. As of June 30, 2023, the percentage of outstanding JV equity interest beneficially owned by the Company was reduced to 42.2%. Such reduction reflects (i) the sale by the Company of approximately 2.1% of the outstanding JV equity interest which resulted in the deconsolidation of the JV Company, (ii) additional sale by the Company of approximately 1.1% of outstanding JV equity interest in December 2021, (iii) the adoption of an employee equity incentive plan and the issuance of additional equity interest equivalent to 3.99% of the JV Company to investors in exchange for cash in December 2021, and (iv) issuance of additional equity interest of JV to investors in January 2022.
Certain Significant Risks and Uncertainties Related to Outbreak of Coronavirus Disease 2019 (“COVID-19”)

During the first half of calendar year 2022, the Company's operations were negatively impacted by China’s zero-Covid policy that resulted in factory shutdowns and supply chain shortages, including the temporary suspension of our factory operations in Shanghai from April to June 2022. In December 2022, the Chinese government issued new guidelines easing some of its strict zero-COVID policies, including the relaxation of testing requirements and travel restrictions. During the three months ended March 31, 2023, China and other parts of the world in which we conduct our business have ended pandemic restriction and have largely returned to normal. In general, our business operations are no longer affected by the COVID-19 pandemic.
Risks and Uncertainties

The Company is subject to certain risks and uncertainties. The Company believes changes in any of the following areas could have a material adverse effect on the Company's future financial position or results of operations or cash flows: the macroeconomic condition and cyclical nature of the semiconductor industry; the timing and success of new product development, including market receptiveness, operation of in-house manufacturing facilities, litigation or claims against the Company based on intellectual property, patent, product regulatory or other factors, competition from other products, general economic conditions, the inability to attract and retain qualified employees, lack of control to the JV Company and ultimately to sustain profitable operations, risks associated with doing business in China, and ability to diversify products and develop digital business; the general state of the U.S., China and world economies; the loss of any of its larger customers; restrictions on the
Company’s ability to sell to foreign customers due to trade laws, regulations and requirements; disruptions of the supply chain of components needed for our products; inability to obtain additional financing; inability to meet certain debt covenants; fundamental changes in the technology underlying the Company’s products; successful and timely completion of product design efforts; and new product design introductions by competitors. Additional risks and uncertainties that the Company is unaware of, or that the Company currently believes are not material, may also become important factors that adversely affect its business.

The Company's revenue is limited by its ability to utilize wafer production and packaging and testing capacity from its in-house facilities and obtain adequate wafer supplies from third-party foundries. The Company entered into an agreement with the JV Company pursuant to which the JV Company agrees to provide the Company with a guaranteed supply of a fixed number of wafers until December 2023. Currently the Company's main third-party foundry is Shanghai Hua Hong Grace Electronic Company Limited, or HHGrace, located in Shanghai, China. HHGrace has been manufacturing wafers for the Company since 2002. HHGrace manufactured approximately 9.6%, 10.3% and 11.5% of the wafers used in the Company's products for the fiscal years ended June 30, 2023, 2022 and 2021, respectively. Although the Company believes that its volume of production allows the Company to secure favorable pricing and priority in allocation of capacity in its third-party foundries, if the foundries' capacities are constrained due to market demands, HHGrace, together with other foundries from which the Company purchases wafers, may not be willing or able to satisfy all of the Company's manufacturing requirements on a timely basis and/or at favorable prices. In addition, manufacturing facilities' capacity affects the Company's gross margin because the Company has certain fixed costs associated with its Oregon Fab as well as in-house packaging and testing facilities. If the Company fails to utilize its manufacturing facilities' capacity at a desirable level, its financial condition and results of operations will be adversely affected.
Use of Estimates
The preparation of the consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses. To the extent there are material differences between these estimates and actual results, the Company's consolidated financial statements will be affected. On an ongoing basis, the Company evaluates the estimates, judgments and assumptions including those related to stock rotation returns, price adjustments, allowance for doubtful accounts, inventory reserves, warranty accrual, income taxes, leases, share-based compensation, recoverability of and useful lives for property, plant and equipment and intangible assets, as well as the economic implications of the COVID-19 pandemic.
Foreign Currency Transactions and Translation
Most of the Company's principal subsidiaries use U.S. dollars as their functional currency because their transactions are primarily conducted and settled in U.S. dollars. All of their revenues and a significant portion of their operating expenses are denominated in U.S. dollars. The functional currencies for the Company's in-house packaging and testing facilities in China are U.S. dollars, and a majority of their capital expenditures are denominated in U.S. dollars. Foreign currency transactions are translated into the functional currencies using the exchange rates prevailing at the dates of the transactions. Foreign exchange gains and losses, resulting from the settlement of such transactions and from the re-measurement of monetary assets and liabilities denominated in foreign currencies using exchange rates at balance sheet date and non-monetary assets and liabilities using historical exchange rates, are recognized in the consolidated statements of operations.
For the Company's subsidiaries which use the local currency as their functional currency, their results and financial position are translated into U.S. dollars using exchange rates at balance sheet dates for assets and liabilities and using average exchange rates for income and expenses items. The resulting translation differences are presented as a separate component of accumulated other comprehensive income (loss) and noncontrolling interest in the consolidated statements of equity.
Cash, Cash Equivalents and Restricted Cash
Cash and cash equivalents primarily consist of cash on hand and short-term bank deposits with original maturities of three months or less. Cash equivalents are highly liquid investments with stated maturities of three months or less as of the dates of purchase. The carrying amounts reported for cash and cash equivalents are considered to approximate fair values based upon their short maturities.

Cash and cash equivalents are maintained with reputable major financial institutions. If, due to current economic conditions or other factors, one or more of the financial institutions with which the Company maintains deposits fails, the Company's cash and cash equivalents may be at risk. Deposits with these banks may exceed the amount of insurance provided on such deposits; however, these deposits typically may be redeemed upon demand and, therefore, bear minimal risk.
The Company maintains restricted cash in connection with cash balances temporarily restricted for regular business operations. These balances have been excluded from the Company’s cash and cash equivalents balance and are classified as restricted cash in the Company’s consolidated balance sheets. As of June 30, 2023 and 2022, the amount of restricted cash was $0.4 million and $0.3 million, respectively.
Accounts Receivable, net
The allowance for doubtful accounts is based on assessment of the collectability of accounts receivable from customers. The Company reviews the allowance by considering factors such as historical collection experience, credit quality, age of the accounts receivable balances and current economic conditions that may affect a customer's ability to pay. The Company writes off a receivable and charges against its recorded allowance when it has exhausted its collection efforts without success.

Fair Value Measurements
    Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value, which are the following:
Level 1 - Quoted prices in active markets for identical assets or liabilities.
Level 2 - Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
Fair Value of Financial Instruments
The fair value of cash equivalents is based on observable market prices and have been categorized in Level 1 in the fair value hierarchy. Cash equivalents consist primarily of short-term bank deposits. The carrying values of financial instruments such as cash and cash equivalents, accounts receivable and accounts payable approximate their carrying values due to their short-term maturities. The carrying value of the Company's debt is considered a reasonable estimate of fair value which is estimated by considering the current rates available to the Company for debt of the same remaining maturities, structure and terms of the debts.
Inventories

The Company carries inventories at the lower of cost (determined on a first-in, first-out basis) or net realizable value. Cost includes semiconductor wafer and raw materials, labor, depreciation expenses and other manufacturing expenses and overhead, and packaging and testing fees paid to third parties if subcontractors are used. Valuation of inventories are based on the Company's periodic review of inventory quantities on hand as compared with its sales forecasts, historical usage, aging of inventories, production yield levels and current product selling prices. If actual market conditions are less favorable than those forecasted by management, additional future inventory write-downs may be required that could adversely affect the Company's operating results. Adjustments to inventory once established are not reversed until the related inventory has been sold or scrapped. If actual market conditions are more favorable than expected and the products that have previously been written down are sold, our gross margin would be favorably impacted.
Property, Plant and Equipment
Property, plant and equipment are stated at historical cost less accumulated depreciation. Historical cost includes expenditures that are directly attributable to the acquisition of the items and the costs incurred to make the assets ready for their intended use.
Depreciation is provided for on a straight-line basis over the estimated useful lives of the related assets as follows:
 
Building and building improvements
20 years
Manufacturing machinery and equipment
7 to 10 years
Equipment and tooling
3 to 5 years
Computer hardware and software
3 to 5 years
Office furniture and equipment
3 to 5 years
Leasehold improvements
2 to 15 years
Vehicle
5 years

Equipment and construction in progress represent equipment received but the necessary installation has not been fully performed or building construction and leasehold improvements have been started but not yet completed. Equipment and construction in progress are stated at cost and transferred to respective asset class when fully completed and ready for their intended use.
Internal-use software development costs are capitalized to the extent that the costs are directly associated with the development of identifiable and unique software products controlled by the Company that will probably generate economic benefits beyond one year. Costs incurred during the application development stage are required to be capitalized. The application development stage is characterized by software design and configuration activities, coding, testing and installation. Training costs and maintenance are expensed as incurred, while upgrades and enhancements are capitalized if it is probable that such expenditures will result in additional functionality. Costs include employee costs incurred and fees paid to outside consultants for the software development and implementation. Internally developed software is amortized over its estimated useful life of three to five years starting from the date when it is ready for its intended use.
Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognized as selling, general and administrative expenses in the consolidated statements of operations. Costs of maintenance and repairs that do not improve or extend the lives of the respective assets are expensed as incurred.
Government Grants
The Company occasionally receives government grants that provide financial assistance for certain eligible expenditures in China. These grants include reimbursements on interest expense on bank borrowings, payroll tax credits, credit for property, plant and equipment in a particular geographical location, employment credits as well as business expansion credits. Government grants are not recognized until there is reasonable assurance that the Company will comply with the conditions attaching to it, and that the grant will be received. The Company records such grants either as a reduction of the related expense, a reduction of the cost of the related asset, or as other income depending upon the nature of the grant. As a result of such grants, during the fiscal year ended June 30, 2023, the Company reduced property, plant and equipment by $0.6 million and operating expenses by $0.1 million. During the fiscal year ended June 30, 2022, the Company reduced interest expense by $0.9 million, property, plant and equipment by $1.4 million, and operating expenses by $0.2 million. During the fiscal year ended June 30, 2021, the Company reduced interest expenses by $3.0 million, property, plant and equipment by $0.1 million, and operating expenses by $3.7 million.

Long-lived Assets

The Company reviews all long-lived assets whenever events or changes in circumstance indicate that these assets may not be recoverable. When evaluating long-lived assets, if the Company concludes that the estimated undiscounted cash flows attributable to the assets are less than their carrying value, the Company recognizes an impairment loss based on the excess of the carrying amount of the assets over their respective fair values, which could adversely affect our results of operations.

There was no impairment of long-lived assets for fiscal years 2023, 2022 and 2021.

Revenue Recognition

The Company determines revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract; and (5) recognition of revenue when, or as, a performance obligation is satisfied. The Company recognizes product revenue at a point in time when product is shipped to the customer, as determined by the agreed upon shipping terms, net of estimated stock rotation returns and price adjustments that it
expects to provide to certain distributors. The Company presents revenue net of sales taxes and any similar assessments. Our standard payment terms range from 30 to 60 days.

The Company sells its products primarily to distributors, who in turn sell the products globally to various end customers. The Company allows stock rotation returns from certain distributors. Stock rotation returns are governed by contract and are limited to a specified percentage of the monetary value of products purchased by distributors during a specified period. The Company records an allowance for stock rotation returns based on historical returns, current expectations, and individual distributor agreements. The Company also provides special pricing to certain distributors, primarily based on volume, to encourage resale of the Company's products. Allowance for price adjustments is recorded against accounts receivable and the provision for stock rotation rights is included in accrued liabilities on the consolidated balance sheets.

The Company's performance obligations relate to contracts with a duration of less than one year. The Company elected to apply the practical expedient provided in ASC 606, “Revenue from Contracts with Customers”. Therefore, the Company is not required to disclose the aggregate amount of transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period.

The Company recognizes the incremental direct costs of obtaining a contract, which consist of sales commissions, when control over the products they relate to transfers to the customer. Applying the practical expedient, the Company recognizes commissions as expense when incurred, as the amortization period of the commission asset the Company would have otherwise recognized is less than one year.

Packaging and testing services revenue is recognized at a point in time upon shipment of serviced products to the customer.

License and Development Services Revenue Recognition

In February 2023, the Company entered into a license agreement with a customer to license the Company’s proprietary SiC technology and to provide 24-months of engineering and development services for a total fee of $45 million, consisting of an upfront fee of $18 million and $6.8 million paid to the Company in March 2023 and July 2023, respectively, with the remaining amount to be paid upon the achievement of specified engineering services and product milestones. The license and development fee is determined to be one performance obligation and is recognized over the 24 months when the Company performs the engineering and development services. The Company uses the input method to measure progression, representing a faithful depiction of the transfer of services. During the fiscal year ended June 30, 2023, the Company recorded $9.9 million of license and development revenue. The amount of contract liability is recorded as deferred revenue on the consolidated balance sheets. In addition, the Company also entered an accompanying supply agreement to provide limited wafer supply to the customer.
Leases

The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets, current operating lease liabilities and long-term operating lease liabilities on the Company's consolidated balance sheets. Finance leases are included in property, plant and equipment, finance lease liabilities and long-term finance leases liabilities on the consolidated balance sheets.

Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. The Company determined its incremental borrowing rate based on the information available at the lease commencement date. The operating lease ROU assets also include any lease payments made and exclude lease incentives. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. Operating lease expense is generally recognized on a straight-line basis over the lease term. Variable lease payments are expensed as incurred and are not included within the operating lease ROU asset and lease liability calculation. The Company does not record leases on the consolidated balance sheet with a term of one year or less. The Company elected to combine its lease and non-lease components as a single lease component for all asset classes.

Product Warranty

The Company provides a standard one-year warranty for the products from the date of purchase by the end customers. The Company accrues for estimated warranty costs at the time revenue is recognized. The Company's warranty obligation is affected by product failure rates, labor and material costs for replacing defective parts, related freight costs for failed parts and other quality assurance costs. The Company monitors its product returns for warranty claims and maintains warranty reserves based on historical experiences and anticipated warranty claims known at the time of estimation.
Shipping and Handling Costs
Shipping and handling costs are included in cost of goods sold.
Research and Development
Research and development costs are expensed as incurred.
 
Provision for Income Taxes

Income tax expense or benefit is based on income or loss before taxes. Deferred tax assets and liabilities are recognized principally for the expected tax consequences of temporary differences between the tax basis of assets and liabilities and their reported amounts.

The Company is subject to income taxes in a number of jurisdictions. Significant judgment is required in determining the worldwide provision for income taxes. There are many transactions and calculations for which the ultimate tax determination is uncertain during the ordinary course of business. The Company establishes accruals for certain tax contingencies based on estimates of whether additional taxes may be due. While the final tax outcome of these matters may differ from the amounts that were initially recorded, such differences will impact the income tax and deferred tax provisions in the period in which such determination is made.

Significant management judgment is also required in determining whether deferred tax assets will be realized in full or in part. When it is more likely than not that all or some portion of specific deferred tax assets such as net operating losses or research and experimentation tax credit carryforwards will not be realized, a valuation allowance must be established for the amount of the deferred tax assets that cannot be realized. The Company considers all available positive and negative evidence on a jurisdiction-by-jurisdiction basis when assessing whether it is more likely than not that deferred tax assets are recoverable. The Company considers evidence such as our past operating results, the existence of cumulative losses in recent years and our forecast of future taxable income. The Company has concluded that it should report a full valuation allowance on its state research and development (R&D) tax credit carryforwards as the Company annually generates more state R&D tax credits than it could use based on its forecasts.

The Financial Accounting Standards Board (FASB), issued guidance which clarifies the accounting for income taxes by prescribing a minimum probability threshold that a tax position must meet before a financial statement benefit is recognized. The minimum threshold is defined as a tax position that is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. The tax benefit to be recognized is measured as the largest amount of benefit that is greater than fifty percent likely to be realized upon ultimate settlement. Although the guidance on the accounting for uncertainty in income taxes prescribes the use of a recognition and measurement model, the determination of whether an uncertain tax position has met those thresholds will continue to require significant judgment by management. If the ultimate resolution of tax uncertainties is different from what is currently estimated, a material impact on income tax expense could result.

The Company's provision for income taxes is subject to volatility and could be adversely impacted by changes in earnings or tax laws and regulations in various jurisdictions. The Company is subject to the continuous examination of our income tax returns by the Internal Revenue Service and other tax authorities. The Company regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of our provision for income taxes. To the extent that the final tax outcome of these matters is different from the amounts recorded, such differences will impact the provision for income taxes in the period in which such determination is made. The provision for income taxes includes the impact of changes to reserves, as well as the related net interest and penalties.
Share-based Compensation Expense

The Company maintains an equity-settled, share-based compensation plan to grant restricted share units and stock options. The Company recognizes expense related to share-based compensation awards that are ultimately expected to vest based on estimated fair values on the date of grant. The fair value of restricted share units is based on the fair value of the Company's common share on the date of grant. For restricted stock awards subject to market conditions, the fair value of each restricted stock award is estimated at the date of grant using the Monte-Carlo pricing model. The fair value of stock options is estimated on the date of grant using the Black-Scholes option valuation model. Share-based compensation expense is recognized on the accelerated attribution basis over the requisite service period of the award, which generally equals the vesting period. The Black-Scholes option valuation model requires the input of subjective assumptions, including the expected term and stock price volatility. In addition, judgment is also required in estimating the number of stock-based awards that are expected to be forfeited. Forfeitures are estimated based on historical experience at the time of grant. Changes in estimated forfeitures are
recognized in the period of change and impact the amount of stock compensation expenses to be recognized in future periods, which could be material if actual results differ significantly from estimates.

The Employee Share Purchase Plan (the “ESPP”) is accounted for at fair value on the date of grant using the Black-Scholes option valuation model.

Advertising

Advertising expenditures are expensed as incurred. Advertising expense was $0.5 million, $0.2 million and $0.4 million in the fiscal years ended June 30, 2023, 2022, and 2021, respectively.
Comprehensive Income (Loss)
Comprehensive income (loss) is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. The Company's accumulated other comprehensive income (loss) consists of cumulative foreign currency translation adjustments.

Recent Accounting Pronouncements
Recently Issued Accounting Standards not yet adopted

In September 2022, the FASB issued ASU No. 2022-04, Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations. This ASU was issued in response to requests from financial statement users for increased transparency surrounding the use of supplier finance programs. The amendments in ASU 2022-04 require that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The amendments in this ASU do not affect the recognition, measurement, or financial statement presentation of obligations covered by supplier finance programs. The amendments in this ASU are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. The Company is currently evaluating the impact of adopting this guidance.
Recently Adopted Accounting Standards

In November 2021, the FASB issued Accounting Standards Update (ASU) No. 2021-10, Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance. This ASU requires business entities to make annual disclosures about transactions with a government they account for by analogizing to a grant or contribution accounting model under ASC 958-605. The adoption of ASU 2021-10 in the fiscal year ended June 30, 2023 on a prospective basis had no impact on the Company's Consolidated Financial Statements.

In August 2020, the FASB issued ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which, among other things, provides guidance on how to account for contracts on an entity’s own equity. This ASU simplifies the accounting for certain financial instruments with characteristics of liabilities and equity. Specifically, the ASU eliminated the need to assess whether a contract on the entity’s own equity (1) permits settlement in unregistered shares, (2) whether counterparty rights rank higher than shareholder’s rights, and (3) whether collateral is required. In addition, the ASU requires incremental disclosure related to contracts on the entity’s own equity and clarifies the treatment of certain financial instruments accounted for under this ASU on earnings per share. The adoption of ASU 2020-06 had no impact on the Company's Consolidated Financial Statements.
v3.23.2
Equity Method Investment in Equity Investee
12 Months Ended
Jun. 30, 2023
Discontinued Operations and Disposal Groups [Abstract]  
Equity Method Investment in Equity Investee Equity Method Investment in Equity Investee
On December 1, 2021 (the “Effective Date”), Alpha & Omega Semiconductor (Shanghai) Ltd. (“AOS SH”) and Agape Package Manufacturing (Shanghai) Limited (“APM SH”), each a wholly-owned subsidiary of the Company, entered into a share transfer agreement (“STA”) with a third-party investor to sell a portion of the Company's equity interest in the JV Company which consists of a power semiconductor packaging, testing and 12-inch wafer fabrication facility in Chongqing, China (the “Transaction”). The Transaction closed on December 2, 2021 (the “Closing Date”), which reduced the Company’s equity interest in the JV Company from 50.9% to 48.8%. Also, the Company’s right to designate directors on the board of the JV Company was reduced to three (3) out of seven (7) directors, from four (4) directors prior to the Transaction. As a result of the Transaction and other factors, the Company no longer has a controlling financial interest in the JV Company and has determined that the JV Company was deconsolidated from the Company’s Consolidated Financial Statements effective as of the Closing Date. In connection with the deconsolidation and in accordance with ASC 810, the Company recorded a gain on deconsolidation of $399.1 million during the fiscal year ended June 30, 2022 in the Condensed Consolidated Statements of Income. The gain on deconsolidation of the JV Company was calculated as follows:

(in thousands)
Cash received for sales of shares in the JV Company
$16,924 
Fair value of retained equity method investment
393,124 
Carrying amount of non-controlling interest
143,889 
Cumulative translation adjustment removal
1,793 
Carrying amount of net assets of the JV Company at December 1, 2021
(156,637)
Gain on deconsolidation of the JV Company
$399,093 

On December 24, 2021, the Company entered into a share transfer agreement with another third-party investor, pursuant to which the Company sold to this investor 1.1% of outstanding equity interest held by the Company in the JV Company. In addition, the JV Company adopted an employee equity incentive plan and issued an equity interest equivalent to 3.99% of the JV Company in exchange to cash. As a result of these two transactions, the Company owned 45.8% of the equity interest in the JV Company as of December 31, 2021.

On January 26, 2022, the JV Company completed a financing transaction pursuant to a corporate investment agreement (the “Investment Agreement”) between the JV Company and certain third-party investors (the “New Investors”). Under the Investment Agreement, the New Investors purchased newly issued equity interest of the JV Company, representing approximately 7.82% of post-transaction outstanding equity interests of the JV Company, for a total purchase price of RMB 509 million (or approximately USD 80 million based on the currency exchange rate as of January 26, 2022) (the “Investment”). Following the closing of the Investment and as of June 30, 2022, the percentage of outstanding JV equity interest beneficially owned by the Company was reduced to 42.2%.

The net loss associated with these sales of JV Company equity interest held by the Company were recorded in the fiscal year ended June 30, 2022 as follows:

(in thousands)
Gain on 1.1% equity interest sold
$475 
Loss on diluted equity interest from issuance of shares under the employee equity incentive plan
(8,116)
Gain on 7.82% equity interest sol
4,501 
Loss on changes on equity interest of the JV Company, net
$(3,140)

The Company accounts for its investment in the JV Company as an equity method investment and reports its equity in earnings or loss of the JV Company on a three-month lag due to an inability to timely obtain financial information of the JV Company. During the fiscal year ended June 30, 2023 and 2022, the Company recorded $1.4 million and $2.6 million of its equity in loss of the JV Company, respectively, using lag reporting. As of June 30, 2023, the percentage of outstanding JV equity interest beneficially owned by the Company was 42.2%.
Summarized Financial Information

The following table presents summarized financial information for the JV Company as of and for the period from April 1, 2022 through March 31, 2023 and December 2, 2021 through March 31, 2022, using lag reporting (in thousands):

As of March 31, 2023As of March 31, 2022
Current assets$122,324 $198,323 
Non-current assets$333,165 $364,777 
Current liabilities$122,340 $251,988 
Non-current liabilities$36,525 $76,207 
For the period of April 1, 2022 to March 31, 2023For the period of December 2, 2021 to March 31, 2022
Revenue$178,974 $68,972 
Gross loss (income)$(4,502)$870 
Operating expenses$5,939 $2,280 
Net loss$4,906 $6,197 
v3.23.2
Related Party Transactions
12 Months Ended
Jun. 30, 2023
Related Party Transactions [Abstract]  
Related Party Transactions Related Party TransactionsAs of June 30, 2023, the Company owned 42.2% equity interest in the JV Company, which, by definition, is a related party to the Company. The JV Company supplies 12-inch wafers and provides assembly and testing services to AOS. AOS previously sold 8-inch wafers to the JV Company for further assembly and testing services until January 1, 2023, when it changed to consign the 8-inch wafers to the JV Company. Due to the right of offset of receivables and payables with the JV Company, as of June 30, 2023 and 2022, AOS recorded the net amount of $12.0 million and $29.0 million, respectively, as a payable related to equity investee, net, on the Consolidated Balance Sheet. Since the December 2, 2021 deconsolidation of the JV Company and through the fiscal year ended June 30, 2022, the Company purchased finished goods and services of $117.6 million from the JV Company and AOS provided the JV Company with $36.4 million of 8-inch wafers. The purchases by AOS for the fiscal year ended June 30, 2023 were $127.8 million and the sales by AOS for the fiscal year ended June 30, 2023 were $35.6 million.
v3.23.2
Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited
12 Months Ended
Jun. 30, 2023
Earnings Per Share [Abstract]  
Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited Net Income Per Common Share Attributable to Alpha and Omega Semiconductor Limited
Basic net income (loss) per share is computed using the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed using the weighted-average number of common shares outstanding, plus potential shares of common stock during the period. Potential shares of common stock include dilutive shares attributable to the assumed exercise of share options, ESPP shares and vesting of RSUs using the treasury stock method and contingent issuances of common shares related to convertible preferred shares, if dilutive. Under the treasury stock method, potential common shares outstanding are not included in the computation of diluted net income per share if their effect is anti-dilutive.
The following table presents the calculation of basic and diluted net income per share attributable to common shareholders:
 Year Ended June 30,  
 202320222021
(in thousands, except per share data)
Numerator:
Net income attributable to Alpha and Omega Semiconductor Limited$12,364 $453,163 $58,116 
Denominator:
Basic:
Weighted average number of common shares used to compute basic net income per share27,552 26,764 25,786 
Diluted:
Weighted average number of common shares used to compute basic net income per share27,552 26,764 25,786 
Effect of potentially dilutive securities:
Stock options, RSUs and ESPP shares1,976 1,439 1,486 
Weighted average number of common shares used to compute diluted net income per share29,528 28,203 27,272 
Net income per share attributable to Alpha and Omega Semiconductor Limited:
Basic$0.45 $16.93 $2.25 
Diluted$0.42 $16.07 $2.13 
The following potential dilutive securities were excluded from the computation of diluted net income per share as their effect would have been anti-dilutive:
 Year Ended June 30,  
 202320222021
(in thousands)
Employee stock options and RSUs310 277 193 
ESPP309 21 71 
Total potential dilutive securities619 298 264 
v3.23.2
Concentration of Credit Risk and Significant Customers
12 Months Ended
Jun. 30, 2023
Risks and Uncertainties [Abstract]  
Concentration of Credit Risk and Significant Customers Concentration of Credit Risk and Significant Customers
The Company manages its credit risk associated with exposure to distributors and direct customers on outstanding accounts receivable through the application of credit approvals, credit ratings and other monitoring procedures. In some instances, the Company also obtains letters of credit from certain customers.
Credit sales, which are mainly on credit terms of 30 to 60 days, are only made to customers who meet the Company's credit standards, while sales to new customers or customers with low credit ratings are usually made on an advance payment basis. The Company considers its trade accounts receivable to be of good credit quality because its key distributors and direct customers have long-standing business relationships with the Company and the Company has not experienced any significant bad debt write-offs of accounts receivable in the past. The Company closely monitors the aging of accounts receivable from its distributors and direct customers, and regularly reviews their financial positions, where available.
Summarized below are individual customers whose revenue or accounts receivable balances were 10% or higher than the respective total consolidated amounts:
   Year Ended June 30,
Percentage of revenue  2023 2022 2021
Customer A  21.6 % 24.6 % 28.7 %
Customer B  35.6 % 39.7 % 35.4 %
Customer D  14.0 % * *
   June 30,
Percentage of accounts receivable  2023 2022
Customer A  15.3 % 24.6 %
Customer B  17.6 % 36.4 %
Customer C  13.3 % *
Customer D30.9 %12.0 %
* Less than 10%
v3.23.2
Balance Sheet Components
12 Months Ended
Jun. 30, 2023
Balance Sheet Related Disclosures [Abstract]  
Balance Sheet Components Balance Sheet Components
Accounts receivable, net
 
June 30,  
 20232022
(in thousands)
Accounts receivable$62,426 $84,442 
Less: Allowance for price adjustments(39,976)(18,731)
Less: Allowance for doubtful accounts(30)(30)
Accounts receivable, net$22,420 $65,681 
Inventories
 
June 30,
 20232022
(in thousands)
Raw materials$86,620 $67,960 
Work in-process69,426 80,720 
Finished goods27,201 9,360 
 $183,247 $158,040 

Other current assets
 
June 30,
 20232022
(in thousands)
VAT receivable$275 $737 
Other prepaid expenses3,863 3,954 
Prepaid insurance4,162 2,590 
Prepaid maintenance1,697 826 
Prepayments to supplier10,689 257 
Prepaid income tax707 2,086 
Interest receivable135 25 
Other receivables1,138 745 
 $22,666 $11,220 
Property, plant and equipment, net
 
June 30,  
 20232022
(in thousands)
Land$4,877 $4,877 
Building and building improvements26,478 16,691 
Manufacturing machinery and equipment398,757 287,574 
Equipment and tooling32,737 28,052 
Computer equipment and software49,890 46,758 
Office furniture and equipment3,087 2,820 
Leasehold improvements38,787 35,254 
 554,613 422,026 
Less: accumulated depreciation(272,503)(233,340)
 282,110 188,686 
Equipment and construction in progress75,721 129,980 
Property, plant and equipment, net$357,831 $318,666 
Total depreciation expense was $40.4 million, $39.9 million and $49.3 million for fiscal year 2023, 2022 and 2021, respectively.
The Company capitalized $0.5 million, $0.3 million and $0.3 million of software development costs during the fiscal year 2023, 2022 and 2021, respectively. Amortization of capitalized software development costs was $0.4 million in fiscal year 2023, $0.4 million in fiscal year 2022 and $0.5 million in fiscal year 2021. Unamortized capitalized software development costs in each of the periods presented at June 30, 2023 and 2022 were $0.9 million and $0.8 million, respectively.
Other long-term assets
June 30,  
 20232022
(in thousands)
Prepayments for property and equipment$1,717 $6,890 
Investment in privately held companies100 100 
Customs deposit 931 1,708 
Deposit with supplier12,290 6,396 
Other long-term deposits37 18 
Office leases deposits1,274 1,012 
Other3,354 1,553 
 $19,703 $17,677 
Intangible assets, net
 
June 30,  
 20232022
(in thousands)
Patents and technology rights$18,037 $18,037 
Trade name268 268 
Customer relationships1,150 1,150 
19,455 19,455 
Less: accumulated amortization(12,959)(9,674)
6,496 9,781 
Goodwill269 269 
Intangible assets, net$6,765 $10,050 

The Company is amortizing intangible assets of patents and technology rights related to a license agreement with STMicroelectronices International N.V. Amortization expense for intangible assets was $3.3 million, $3.4 million and $3.4 million for the years ended June 30, 2023, 2022 and 2021, respectively. The estimated useful lives for patents and technology rights and trade name were five years and ten years, respectively. Customer relationships are fully amortized.
Estimated future minimum amortization expense of intangible assets is as follows (in thousands):
Year ending June 30,
2024$3,249 
20253,247 
$6,496 
Accrued liabilities
 
June 30,  
 20232022
(in thousands)
Accrued compensation and benefits$15,627 $34,681 
Warranty accrual1,674 2,650 
Stock rotation accrual5,588 4,798 
Accrued professional fees2,458 2,659 
Accrued inventory1,597 2,491 
Accrued facilities related expenses2,327 2,421 
Accrued property, plant and equipment6,402 20,485 
Other accrued expenses4,401 5,159 
Customer deposit38,082 40,578 
ESPP payable1,377 971 
 $79,533 $116,893 
Short-term customer deposits are payments received from customers for securing future product shipments. As of June 30, 2023, $13.5 million were from Customer A and $9.2 million were from Customer B, and $15.4 million were from other customers. As of June 30, 2022, $12.5 million were from Customer A and $16.2 million were from Customer B, and $11.9 million were from other customers.
The activity in the warranty accrual, included in accrued liabilities is as follows:
Year Ended June 30,
202320222021
(in thousands)
Beginning balance$2,650 $2,795 $709 
Addition3,666 1,127 2,443 
Utilization(4,642)(1,272)(357)
Ending balance$1,674 $2,650 $2,795 
    The activity in the stock rotation accrual, included in accrued liabilities is as follows:
Year Ended June 30,
202320222021
(in thousands)
Beginning balance$4,798 $3,917 $3,358 
Addition13,950 5,817 4,742 
Utilization(13,160)(4,936)(4,183)
Ending balance$5,588 $4,798 $3,917 
Other long-term liabilities
 
June 30,  
 20232022
(in thousands)
Customer deposits $46,393 $70,301 
Computer software liabilities4,644 8,302 
Other long-term liabilities$51,037 $78,603 
    Customer deposits are payments received from customers for securing future product shipments. As of June 30, 2023, $21.0 million were from Customer A and $11.7 million were from Customer B, and $13.7 million were from other customers. As of June 30, 2022, $34.5 million were from Customer A and $21.9 million were from Customer B and $13.9 million were from other customers.
v3.23.2
Debt
12 Months Ended
Jun. 30, 2023
Debt Disclosure [Abstract]  
Debt Bank Borrowing
Short-term bank borrowing

In January 2023, one of the Company's subsidiaries in China entered into a line of credit facility with Bank of Communications Limited in China. The purpose of the credit facility is to provide working capital borrowings. The Company could borrow up to approximately RMB 140 million or $20.6 million based on currency exchange rate between RMB and U.S. Dollar on January 31, 2023 with a maturity date of December 1, 2023. As of June 30, 2023, there was no outstanding balance for this loan.

In September 2022, one of the Company's subsidiaries in China entered into a line of credit facility with Industrial and Commercial Bank of China. The purpose of the credit facility was to provide working capital borrowings. The Company could borrow up to approximately RMB 72.0 million or $10.3 million based on currency exchange rate between RMB and U.S. Dollar on September 20, 2022 with a maturity date of September 30, 2023. As of June 30, 2023, there was no outstanding balance.

In October 2019, one of the Company's subsidiaries in China entered into a line of credit facility with Bank of Communications Limited in China. This line of credit matured on February 14, 2021 and was based on the China Base Rate multiplied by 1.05, or 4.99% on October 31, 2019. The purpose of the credit facility is to provide short-term borrowings. The Company could borrow up to approximately RMB 60.0 million or $8.5 million based on the currency exchange rate between the RMB and the U.S. Dollar on October 31, 2019. In September 2021, this line of credit was renewed with maximum borrowings up to RMB 140.0 million with the same terms and a maturity date of September 18, 2022. During the three months ended December 31, 2021, the Company borrowed RMB 11.0 million, or $1.6 million, at an interest rate of 3.85% per annum, with principal due on November 18, 2022. As of June 30, 2023, there was no outstanding balance and this loan was expired.

On November 16, 2018, one of the Company's subsidiaries in China entered into a line of credit facility with Industrial and Commercial Bank of China. The purpose of the credit facility was to provide short-term borrowings. The Company could borrow up to approximately RMB 72.0 million or $10.3 million based on currency exchange rate between RMB and U.S. Dollar on November 16, 2018. The RMB 72.0 million consists of RMB 27.0 million for trade borrowings with a maturity date of December 31, 2021, and RMB 45.0 million for working capital borrowings or trade borrowings with a maturity date of September 13, 2022. During the three months ended December 31, 2021, the Company borrowed RMB 5.0 million, or $0.8 million, at an interest rate of 3.7% per annum, with principal due on September 12, 2022. As of June 30, 2023, there was no outstanding balance and this loan was expired.

Accounts Receivable Factoring Agreement

On August 9, 2019, one of the Company's wholly-owned subsidiaries (the "Borrower") entered into a factoring agreement with the Hongkong and Shanghai Banking Corporation Limited (“HSBC”), whereby the Borrower assigns certain of its accounts receivable with recourse. This factoring agreement allows the Borrower to borrow up to 70% of the net amount of its eligible accounts receivable of the Borrower with a maximum amount of $30.0 million. The interest rate is based on one month
London Interbank Offered Rate ("LIBOR") plus 1.75% per annum. The Company is the guarantor for this agreement. The Company is accounting for this transaction as a secured borrowing under the Transfers and Servicing of Financial Assets guidance. In addition, any cash held in the restricted bank account controlled by HSBC has a legal right of offset against the borrowing. This agreement, with certain financial covenants required, has no expiration date. On August 11, 2021, the Borrower signed an agreement with HSBC to decrease the borrowing maximum amount to $8.0 million with certain financial covenants required. Other terms remain the same. The Borrower was in compliance with these covenants as of June 30, 2023. As of June 30, 2023, there was no outstanding balance and the Company had unused credit of approximately $8.0 million.

Debt financing

In September 2021, Jireh Semiconductor Incorporated (“Jireh”), one of the wholly-owned subsidiaries, entered into a financing arrangement agreement with a company (“Lender”) for the lease and purchase of a machinery equipment manufactured by a supplier. This agreement has a 5 years term, after which Jireh has the option to purchase the equipment for $1. The implied interest rate was 4.75% per annum which was adjustable based on every five basis point increase in 60-month U.S. Treasury Notes, until the final installation and acceptance of the equipment. The total purchase price of this equipment was euro 12.0 million. In April 2021, Jireh made a down payment of euro 6.0 million, representing 50% of the total purchase price of the equipment, to the supplier. In June 2022, the equipment was delivered to Jireh after Lender paid 40% of the total purchase price, for euro 4.8 million, to the supplier on behalf of Jireh. In September 2022, Lender paid the remaining 10% payment for the total purchase price and reimbursed Jireh for the 50% down payment, after the installation and configuration of the equipment. The title of the equipment was transferred to Lender following such payment. The agreement was amended with fixed implied interest rate of 7.51% and monthly payment of principal and interest effective in October 2022. Other terms remain the same. In addition, Jireh purchased hardware for the machine under this financing arrangement. The purchase price of this hardware was $0.2 million. The financing arrangement is secured by this equipment and other equipment which had the carrying amount of $15.2 million as of June 30, 2023. As of June 30, 2023, the outstanding balance of this debt financing was $11.9 million.

Long-term bank borrowings

On August 18, 2021, Jireh entered into a term loan agreement with a financial institution (the "Bank") in an amount up to $45.0 million for the purpose of expanding and upgrading the Company’s fabrication facility located in Oregon. The obligation under the loan agreement is secured by substantially all assets of Jireh and guaranteed by the Company. The agreement has a 5.5 years term and matures on February 16, 2027. Jireh is required to make consecutive quarterly payments of principal and interest. The loan accrues interest based on adjusted LIBOR plus the applicable margin based on the outstanding balance of the loan. This agreement contains customary restrictive covenants and includes certain financial covenants that the Company is required to maintain. Jireh drew down $45.0 million on February 16, 2022 with the first payment of principal beginning in October 2022. As of June 30, 2023, Jireh was in compliance with these covenants and the outstanding balance of this loan was $38.3 million.

On May 1, 2018, Jireh entered into a loan agreement with the Bank that provided a term loan in an amount of $17.8 million. The obligation under the loan agreement is secured by certain real estate assets of Jireh and guaranteed by the Company.  The loan has a five-year term and matures on June 1, 2023. Jireh made consecutive monthly payments of principal and interest to the Bank. The outstanding principal shall accrue interest at a fixed rate of 5.04% per annum on the basis of a 360-day year. The loan agreement contains customary restrictive covenants and includes certain financial covenants that require the Company to maintain, on a consolidated basis, specified financial ratios. In August 2021, Jireh signed an amendment of this loan with the Bank to modify the financial covenants requirement to align with the new term loan agreement entered into on August 18, 2021 discussed above. The amendment was accounted for as a debt modification and no gain or loss was recognized. The Company paid this loan in full on May 1, 2023. As of June 30, 2023, there was no outstanding balance and this loan was expired.

On August 15, 2017, Jireh entered into a credit agreement with the Bank that provided a term loan in an amount up to $30.0 million for the purpose of purchasing certain equipment for the fabrication facility located in Oregon.  The obligation under the credit agreement was secured by substantially all assets of Jireh and guaranteed by the Company.  The credit agreement had a five-year term and matured on August 15, 2022. In January 2018 and July 2018, Jireh drew down on the loan in the amount of $13.2 million and $16.7 million, respectively.  Beginning in October 2018, Jireh was required to pay to the Bank on each payment date, the outstanding principal amount of the loan in monthly installments.  The loan accrued interest based on an adjusted LIBOR as defined in the credit agreement, plus specified applicable margin in the range of 1.75% to 2.25%, based on the outstanding balance of the loan.  The credit agreement contained customary restrictive covenants and included certain financial covenants that required the Company to maintain, on a consolidated basis, specified financial ratios and fixed charge coverage ratio. In August 2021, Jireh signed an amendment of this loan with the Bank to modify the financial covenants requirement to align with the new term loan agreement entered into on August 18, 2021, discussed above. The amendment was accounted for as a debt modification and no gain or loss was recognized. The loan was fully paid off in September, 2022. As of June 30, 2023, there was no outstanding balance and this loan was expired.
At June 30, 2023, maturities of short-term debt and long-term debt were as follows (in thousands):

Year ending June 30,
2024$11,472 
202511,664 
202611,871 
202714,344 
2028536 
Total principal of debt49,887 
Less: debt issuance costs(93)
Total principal of debt, less debt issuance costs$49,794 

Short-term DebtLong-term DebtTotal
Principal amount$11,472 $38,415 $49,887 
Less: debt issuance costs(38)(55)(93)
Total debt, less debt issuance costs$11,434 $38,360 $49,794 
v3.23.2
Leases
12 Months Ended
Jun. 30, 2023
Leases [Abstract]  
Leases Leases
The Company evaluates contracts for lease accounting at contract inception and assesses lease classification at the lease commencement date. Operating leases are included in operating lease right-of-use (“ROU”) assets, operating lease liabilities and operating lease liabilities - long-term on the Company's Consolidated Balance Sheets. Finance leases are included in property, plant and equipment, finance lease liabilities and finance lease liabilities-long-term on the Consolidated Balance Sheets. The Company recognizes a ROU asset and corresponding lease obligation liability at the lease commencement date where the lease obligation liability is measured at the present value of the minimum lease payments. As most of the leases do not provide an implicit rate, the Company uses its incremental borrowing rate at lease commencement. The Company uses an interest rate commensurate with the interest rate to borrow on a collateralized basis over a similar term with an amount equal to the lease payments. Operating leases are primarily related to offices, research and development facilities, sales and marketing facilities, and manufacturing facilities. In addition, long-term supply agreements to lease gas tank equipment and purchase industrial gases are accounted for as operating leases. Lease agreements frequently include renewal provisions and require the Company to pay real estate taxes, insurance and maintenance costs. For operating leases, the amortization of the ROU asset and the accretion of its lease obligation liability result in a single straight-line expense recognized over the lease term. The finance lease is related to the $5.1 million of a machinery lease financing with a vendor. In September 2022, the lease was amended to make a monthly payment of principal and interest as a fixed amount effective in October 2022. Other terms remain the same. The amendment was accounted for as a debt modification and no gain or loss was recognized. The Company does not record leases on the consolidated balance sheet with a term of one year or less.
The components of the Company’s operating and finance lease expenses are as follows for the years presented (in thousands):

Fiscal Year Ended June 30, 2023Fiscal Year Ended June 30, 2022
Operating leases:
     Fixed rent expense$5,779 $6,262 
     Variable rent expense1,014 946 
Finance lease:
     Amortization of equipment522 908 
     Interest306 976 
Short-term leases:
     Short-term lease expenses400 205 
               Total lease expenses$8,021 $9,297 
Supplemental balance sheet information related to the Company’s operating and finance leases is as follows (in thousands, except lease term and discount rate):

June 30, 2023June 30, 2022
Operating Leases:
     ROU assets associated with operating leases$24,349 $23,674 
Finance Lease:
     Property, plant and equipment, gross$5,133 $4,831 
     Accumulated depreciation(657)(136)
          Property, plant and equipment, net$4,476 $4,695 
Weighted average remaining lease term (in years)
     Operating leases6.577.42
     Finance lease4.255.00
Weighted average discount rate
     Operating leases4.67 %4.27 %
     Finance lease7.51 %4.76 %

Supplemental cash flow information related to the Company’s operating and finance lease is as follows (in thousands):

Fiscal Year Ended June 30, 2023Fiscal Year Ended June 30, 2022
Cash paid from amounts included in the measurement of lease liabilities:
     Operating cash flows from operating leases$5,945 $6,480 
     Operating cash flows from finance lease$306 $976 
     Financing cash flows from finance lease$810 $4,176 
Non-cash investing and financing information:
     Operating lease right-of-use assets obtained in exchange for lease obligations$5,579 $5,852 

Future minimum lease payments are as follows as of June 30, 2023 (in thousands):

Operating LeasesFinance Leases
2024$5,452 $1,144 
20254,623 1,144 
20263,807 1,144 
20273,647 1,145 
20283,317 191 
Thereafter8,303 — 
Total minimum lease payments29,149 4,768 
Less amount representing interest(4,222)(685)
Total lease liabilities$24,927 $4,083 
Leases Leases
The Company evaluates contracts for lease accounting at contract inception and assesses lease classification at the lease commencement date. Operating leases are included in operating lease right-of-use (“ROU”) assets, operating lease liabilities and operating lease liabilities - long-term on the Company's Consolidated Balance Sheets. Finance leases are included in property, plant and equipment, finance lease liabilities and finance lease liabilities-long-term on the Consolidated Balance Sheets. The Company recognizes a ROU asset and corresponding lease obligation liability at the lease commencement date where the lease obligation liability is measured at the present value of the minimum lease payments. As most of the leases do not provide an implicit rate, the Company uses its incremental borrowing rate at lease commencement. The Company uses an interest rate commensurate with the interest rate to borrow on a collateralized basis over a similar term with an amount equal to the lease payments. Operating leases are primarily related to offices, research and development facilities, sales and marketing facilities, and manufacturing facilities. In addition, long-term supply agreements to lease gas tank equipment and purchase industrial gases are accounted for as operating leases. Lease agreements frequently include renewal provisions and require the Company to pay real estate taxes, insurance and maintenance costs. For operating leases, the amortization of the ROU asset and the accretion of its lease obligation liability result in a single straight-line expense recognized over the lease term. The finance lease is related to the $5.1 million of a machinery lease financing with a vendor. In September 2022, the lease was amended to make a monthly payment of principal and interest as a fixed amount effective in October 2022. Other terms remain the same. The amendment was accounted for as a debt modification and no gain or loss was recognized. The Company does not record leases on the consolidated balance sheet with a term of one year or less.
The components of the Company’s operating and finance lease expenses are as follows for the years presented (in thousands):

Fiscal Year Ended June 30, 2023Fiscal Year Ended June 30, 2022
Operating leases:
     Fixed rent expense$5,779 $6,262 
     Variable rent expense1,014 946 
Finance lease:
     Amortization of equipment522 908 
     Interest306 976 
Short-term leases:
     Short-term lease expenses400 205 
               Total lease expenses$8,021 $9,297 
Supplemental balance sheet information related to the Company’s operating and finance leases is as follows (in thousands, except lease term and discount rate):

June 30, 2023June 30, 2022
Operating Leases:
     ROU assets associated with operating leases$24,349 $23,674 
Finance Lease:
     Property, plant and equipment, gross$5,133 $4,831 
     Accumulated depreciation(657)(136)
          Property, plant and equipment, net$4,476 $4,695 
Weighted average remaining lease term (in years)
     Operating leases6.577.42
     Finance lease4.255.00
Weighted average discount rate
     Operating leases4.67 %4.27 %
     Finance lease7.51 %4.76 %

Supplemental cash flow information related to the Company’s operating and finance lease is as follows (in thousands):

Fiscal Year Ended June 30, 2023Fiscal Year Ended June 30, 2022
Cash paid from amounts included in the measurement of lease liabilities:
     Operating cash flows from operating leases$5,945 $6,480 
     Operating cash flows from finance lease$306 $976 
     Financing cash flows from finance lease$810 $4,176 
Non-cash investing and financing information:
     Operating lease right-of-use assets obtained in exchange for lease obligations$5,579 $5,852 

Future minimum lease payments are as follows as of June 30, 2023 (in thousands):

Operating LeasesFinance Leases
2024$5,452 $1,144 
20254,623 1,144 
20263,807 1,144 
20273,647 1,145 
20283,317 191 
Thereafter8,303 — 
Total minimum lease payments29,149 4,768 
Less amount representing interest(4,222)(685)
Total lease liabilities$24,927 $4,083 
v3.23.2
Shareholders' Equity
12 Months Ended
Jun. 30, 2023
Stockholders' Equity Note [Abstract]  
Shareholders' Equity Shareholders' Equity
Common Shares

The Company's Bye-laws, as amended, authorized the Company to issue 100,000,000 common shares with par value of $0.002. Each common share is entitled to one vote. The holders of common shares are also entitled to receive dividends whenever funds are legally available and when and if declared by the board of directors. No dividends had been declared as of June 30, 2023.

In September 2017, the board of directors approved a repurchase program (the “Repurchase Program”) that allowed the Company to repurchase its common shares from the open market pursuant to a pre-established Rule 10b5-1 trading plan or through privately negotiated transactions up to an aggregate of $30.0 million. The amount and timing of any repurchases under the Repurchase Program depend on a number of factors, including but not limited to, the trading price, volume and availability of the Company's common shares. Shares repurchased under this program are accounted for as treasury shares and the total cost of shares repurchased is recorded as a reduction of shareholders' equity. From time to time, treasury shares may be reissued as part of the Company's stock-based compensation programs. Gains on re-issuance of treasury stock are credited to additional paid-in capital; losses are charged to additional paid-in capital to offset the net gains, if any, from previous sales or re-issuance of treasury stock. Any remaining balance of the losses is charged to retained earnings.
During fiscal year 2023, the Company repurchased an aggregate of 548,132 shares, from the open market for a total cost of approximately $13.4 million, excluding fees and related expenses, at an average price of $24.51 per share. During fiscal year 2022 and 2021, the Company did not repurchase any shares pursuant to the repurchase program.
As of June 30, 2023, the Company had repurchased an aggregate of 7,332,780 shares for a total cost of $81.1 million, at an average price of $11.01 per share, excluding fees and related expenses, since inception of the program. No repurchased shares have been retired. Of the 7,332,780 repurchased shares, 175,599 shares with a weighted average repurchase price of $9.97 per share, were reissued at an average price of $4.76 per share for option exercises and vested restricted stock units (“RSU”). As of June 30, 2023, there was none remaining available under the share repurchase program.
v3.23.2
Share-based Compensation
12 Months Ended
Jun. 30, 2021
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Share-based Compensation Share-based Compensation
2018 Omnibus Incentive Plan
The 2009 Share Option/Share Issuance Plan (the “2009 Plan”) was approved in September 2009 at the annual general meeting of shareholders in connection with the Company's IPO. At the annual general meeting of shareholders in November 2018, the 2009 Plan was approved to be terminated and the 2018 Omnibus Incentive Plan (the “2018 Plan”) was effective. No further awards will be made under the 2009 Plan. The 2018 Plan authorized the board of directors to grant incentive share options, non-statutory share options and restricted shares to employees, directors, non-employee directors and consultants of the Company and its subsidiaries for up to 2,065,000 common shares. The 2018 Plan does not include an evergreen authorization Therefore, the Company is not permitted to increase the number of shares reserved in the share pool without obtaining further shareholder approval. Outstanding shares under the 2018 Plan and awards granted under the 2009 Plan that expire, are forfeited or cancelled or terminate prior to the issuance of the shares subject to those awards or are settled in cash will be available for subsequent issuance under the 2018 Plan. At the annual general meeting of shareholders in November 2021 and 2022, the 2018 Plan was approved to increase by 1,000,000 and 740,000 shares, respectively, to a total of 3,805,000 shares. As of June 30, 2023, 611,994 shares were available for grant under the 2018 Plan.
Beginning with the 2014 Annual Shareholders Meeting, on the date of each annual shareholders meeting, each individual who commences service as a non-employee Board member by reason of his or her election to the Board at such annual meeting and each individual who is to continue to serve as a non-employee Board member, whether or not that individual is standing for re-election to the Board at that particular annual meeting, will automatically be granted an award in the form of restricted share units covering that number of common shares determined by dividing one hundred thirty-five thousand dollars ($135,000) by the average fair market value per share for the ninety (90)-day period preceding the grant date, up to a maximum of 10,000 shares.

Under the 2018 Plan, incentive share options and RSU are to be granted at a price that is not less than 100% and nonstatutory share options are to be granted at not less than 85% of the fair value of the common shares, at the date of grant for employees and consultants. Options and RSUs generally vest over a four-year to five-year period, and are exercisable for a maximum period of ten years after the date of grant.
The fair value of RSU, including time-based restricted stock units and performance-based restricted stock units is based on the market price of the Company's share on the date of grant.

Time-based Restricted Stock Units (“TRSU”)

The following table summarizes the Company's TRSU activities:
 
 Number of Restricted Stock
Units
Weighted Average
Grant Date Fair
Value Per Share
Weighted Average
Remaining
Recognition
Period (Years)
Aggregate Intrinsic Value
Nonvested at June 30, 2020932,138 $11.36 1.66$10,141,661 
Granted722,873 $29.85 
Vested(567,087)$15.70 
Forfeited(34,400)$14.88 
Nonvested at June 30, 20211,053,524 $21.60 1.73$32,016,594 
Granted597,381 $45.83 
Vested(410,670)$20.54 
Forfeited(70,626)$26.79 
Nonvested at June 30, 20221,169,609 $34.03 1.73$38,994,764 
Granted714,080 $27.70 
Vested(451,549)$28.84 
Forfeited(47,075)$33.40 
Nonvested at June 30, 20231,385,065 $32.48 1.73$45,430,132 
Performance-based Restricted Stock Units (“PRSU”)

In March each year since fiscal year 2017, the Company granted PRSU to certain personnel. The number of shares to be ultimately earned under the PRSU is determined based on the level of attainment of predetermined financial goals. The PRSU vests in four equal annual installments from the first anniversary date after the grant date if certain predetermined financial goals were met. The Company recorded $5.2 million, $4.6 million and $2.3 million of expenses for these PRSUs during the years ended June 30, 2023, 2022 and 2021, respectively.

During the quarter ended June 30, 2019, the Company announced an incentive program. Under this program, each participant’s award is denominated in stock and subject to achievement of certain objective goals within certain timelines. In June 2020, the Company believed it was most likely that predetermined goal measures would be met. Therefore, the Company reported such expenses in the other current liabilities line on the condensed consolidated balance sheets as the amount of bonus is to be settled in variable number of RSU’s at the completion of the objective goals. Such non-cash compensation expense was recorded as part of share-based compensation expense in the condensed consolidated statements of operations. As of June 30, 2022 and 2021, the Company recorded nil and $0.1 million such expenses in the other current liabilities, respectively. During the fiscal years ended June 30, 2022, 2021 and 2020, the Company recorded $0.3 million, $3.1 million and $0.6 million of non-cash compensation expense, respectively. As of June 30, 2022, the Company granted RSUs valued at $4.0 million to participants, which were fully vested due to achievement of certain objective measures.

The following table summarizes the Company’s PRSU activities:
Number of Performance-based Restricted Stock
Units
Weighted Average
Grant Date Fair
Value Per Share
Weighted Average
Remaining
Recognition
Period (Years)
Aggregate Intrinsic Value
Nonvested at June 30, 2020342,775 $12.38 1.60$3,729,392 
Granted165,500 $36.27 
Vested(148,211)$14.24 
Forfeited(6,240)$17.23 
Nonvested at June 30, 2021353,824 $22.69 1.74$10,752,711 
Granted194,000 $48.65 
Vested(151,199)$19.44 
Forfeited(7,250)$40.33 
Nonvested at June 30, 2022389,375 $36.56 1.85$12,981,763 
Granted264,214 $25.70 
Vested(116,132)$30.54 
Forfeited(10,743)$48.65 
Nonvested at June 30, 2023526,714 $32.19 1.78$17,276,219 

Market-based Restricted Stock Units (“MSUs”)

In December 2021, the Company granted 1.0 million market-based restricted stock units (“MSUs”) to its certain personnel. The number of shares to be earned at the end of performance period is determined based on the Company’s achievement of specified stock prices and revenue thresholds during the performance period from January 1, 2022 to December 31, 2024 as well as the recipients remaining in continuous service with the Company through such period. The MSU vests in four equal annual installments after the end of performance period. The Company estimated the grant date fair values of its MSU with derived service periods of 4.1 to 7.1 years using a Monte-Carlo simulation model with the following assumptions: Risk-free interest rate of 1.0%, expected term of 3.1 years, expected volatility of 62.8% and dividend yield of 0%. The Company recorded approximately $1.9 million and $4.5 million of expenses for these MSUs during the fiscal year ended June 30, 2023 and 2022, respectively.

During the quarter ended September 30, 2018, the Company granted 1.3 million MSUs to certain personnel. The number of shares to be earned at the end of the performance period is determined based on the Company’s achievement of specified stock prices and revenue thresholds during the performance period from January 1, 2019 to December 31, 2021 as well as the
recipients remaining in continuous service with the Company through such period. The MSUs vest in four equal annual installments after the end of performance period. On August 31, 2020, the Compensation Committee of the Board approved a modification of the terms of MSU to (i) extend the performance period through December 31, 2022 and (ii) change the commencement date for the four-year time-based service period to January 1, 2023. The modified MSUs were valued immediately before and after the modification, using Monte-Carlo simulation pricing model. The Monte-Carlo simulation pricing model applied the following assumptions for pre-modification conditions: risk-free interest rate of 0.13%, expected term of 1.3 years, expected volatility of 66.7% and dividend yield of 0%; and for post-modification conditions: risk-free interest rate of 0.14%, expected term of 2.3 years, expected volatility of 59.1% and dividend yield of 0%. The fair value of these MSUs was recalculated to reflect the change as of August 31, 2020 and the unrecognized compensation amount was adjusted to reflect the increase in fair value. The Company recorded approximately $3.9 million, $1.6 million and $1.2 million of expense for these MSUs during the years ended June 30, 2023, 2022 and 2021, respectively.

The following table summarizes the Company’s MSUs activities:
Number of Performance-based Restricted Stock
Units
Weighted Average
Grant Date Fair
Value Per Share
Weighted Average
Remaining
Recognition
Period (Years)
Aggregate Intrinsic Value
Nonvested at June 30, 20201,290,000 $5.17 3.88$14,035,200 
Forfeited(50,000)$5.17 
Nonvested at June 30, 20211,240,000 $5.17 3.84$37,683,600 
Granted1,022,000 $48.44 
Forfeited(56,000)$9.81 
Nonvested at June 30, 20222,206,000 $25.10 3.83$73,548,040 
Vested(90,000)$5.17 
Forfeited(8,000)$48.44 
Nonvested at June 30, 20232,108,000 $25.86 2.96$69,142,400 
Stock Option
The following table summarizes the Company's stock option activities:
Weighted
WeightedAverage
AverageRemaining
Number ofExercise PriceContractual Aggregate
SharesPer ShareTerm (in years)Intrinsic Value
Outstanding at June 30, 2020643,978 $8.79 2.89
Granted— $— 
Exercised(156,103)$11.31 $1,272,291 
Canceled or forfeited— $— 
Outstanding at June 30, 2021487,875 $7.99 2.32
Granted— $— 
Exercised(98,000)$9.15 $3,936,675 
Canceled or forfeited— $— 
Outstanding at June 30, 2022389,875 $7.70 1.53
Granted— $— 
Exercised(65,500)$8.42 $1,442,646 
Canceled or forfeited(5,000)$9.19 
Outstanding at June 30, 2023319,375 $7.53 0.72$8,071,631 
Options vested and expected to vest319,375 $7.53 0.72$8,071,631 
Exercisable at June 30, 2023319,375 $7.53 0.72$8,071,631 
The aggregate intrinsic value for options outstanding at June 30, 2023 in the table above is based on the Company’s common stock closing price on June 30, 2023.
The 2018 Employee Share Purchase Plan
At the annual general meeting of shareholders in November 2018, the 2018 Employee Share Purchase Plan (“Purchase Plan” or “ESPP”) Plan was approved, under which 1,430,000 common shares are available for issuance. The Purchase Plan does not include an evergreen authorization, therefore the Company is not permitted to increase the number of shares reserved in the share pool without obtaining further shareholder approval. At the general meeting of shareholders in November 2021, the ESPP Plan was approved to increase from 1,430,000 shares to 2,500,000 shares. The Purchase Plan provided for a series of overlapping offering periods with a duration of 24 months, generally beginning on May 15 and November 15 of each year. The Purchase Plan allows employees to purchase common shares through payroll deductions of up to 15% of their eligible compensation. Such deductions will accumulate over a six-month accumulation period without interest. After such accumulation period, common shares will be purchased at a price equal to 85% of the fair market value per share on either the first day of the offering period or the last date of the accumulation period, whichever is less. The maximum number of shares that may be purchased by a participant on any purchase date may not exceed 875 shares for a total of 3,500 shares per a 24-month offering period. In addition, no participant may purchase more than $25,000 worth of common stock in any one calendar year period. No more than 300,000 common shares may be purchased by all participants on any purchase date.
The ESPP is compensatory and results in compensation expense. The fair values of common shares to be issued under the ESPP were determined using the Black-Scholes option pricing model with the following assumptions:
Year Ended June 30,
202320222021
Volatility rate
64.0% - 70.5%
66.4% - 69.9%
63.1% - 68.5%
Risk-free interest rate
4.5% - 4.6%
0.3% - 2.1%
0.1% - 0.2%
Expected term1.3 years1.3 years1.3 years
Dividend yield—%—%—%

The weighted-average estimated fair value of employee stock purchase rights granted pursuant to the ESPP during the years ended June 30, 2023, 2022 and 2021 was $11.46, $16.48 and $11.11 per share, respectively.
Share-based Compensation Expenses
The total share-based compensation expense related to TRSU, PSUs, MSUs, stock options and ESPP described above, recognized in the consolidated statements of operations for the years presented was as follows:
Year Ended June 30,
202320222021
(in thousands)
Cost of goods sold$5,851 $5,125 $1,756 
Research and development9,437 7,049 5,352 
Selling, general and administrative22,200 19,150 8,216 
$37,488 $31,324 $15,324 
Total unrecognized share-based compensation expense as of June 30, 2023 was $56.1 million including estimated forfeitures, which is expected to be recognized over a weighted-average period of 2.2 years.
v3.23.2
Employee Benefit Plans
12 Months Ended
Jun. 30, 2023
Retirement Benefits [Abstract]  
Employee Benefit Plans Employee Benefit Plans The Company maintains a 401(k) retirement plan for the benefit of qualified employees in the U.S. Employees who participate may elect to make salary deferral contributions to the plan up to 100% of the employees' eligible salary subject to annual Internal Revenue Code maximum limitations. The employer's contribution is discretionary. Effective from April 1, 2022, the Company begins to match 50% of employee contribution up to 4% of eligible compensation for a 2% maximum match. During the fiscal year ended June 30, 2023 and 2022, the Company made employer match contributions of $1.0 million and $0.3 million, respectively.The Company makes mandatory contributions for its employees to the respective local governments in terms of retirement, medical insurance and unemployment insurance, where applicable, according to labor and social security laws and regulations of the countries and areas in which the Company operates. The retirement contribution rate is 7.7% in the U.S., 15.0% to 16.0% in China, 6.0% in Taiwan, and 12.0% in India. The Company has no obligations for the payment of such social benefits beyond the required contributions as set out above.
v3.23.2
Income Taxes
12 Months Ended
Jun. 30, 2023
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
    The provision for income taxes is comprised of:
Year Ended June 30, 
202320222021
(in thousands)
U.S. federal taxes:
Current$1,093 $645 $31 
Deferred549 2,260 1,955 
Non-U.S. taxes:
Current4,620 7,749 2,344 
Deferred(404)28,599 (396)
State taxes, net of federal benefit:
Current79 
Total provision for income taxes$5,937 $39,258 $3,935 
The reconciliation of the federal statutory income tax rate to our effective income tax rate is as follows (in percentage):

 Year Ended June 30,
 202320222021
United States statutory rate21.0 %21.0 %21.0 %
Stock-based compensation0.2 0.0 0.1 
Foreign taxes, net13.5 (14.3)(14.4)
Outside basis difference on equity method investment(1.0)1.2 — 
Tax credits (13.3)(0.3)(2.4)
Non-deductible expenses1.5 — 2.4 
Tax exempt income(1.5)— — 
Withholding taxes9.0 — — 
Non-deductible executive compensation7.3 0.5 — 
Foreign derived intangible income deduction(7.2)(0.3)— 
Other0.6 0.1 (0.2)
 30.1 %7.9 %6.5 %
    The domestic and foreign components of income before taxes are:
 Year Ended June 30, 
 202320222021
(in thousands)
U.S. operations$19,001 $16,684 $9,622 
Non-U.S. operations711 478,386 50,602 
Net income before income taxes$19,712 $495,070 $60,224 
    Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of our deferred tax assets and liabilities are as follows:
 June 30, 
 20232022
(in thousands)
Deferred tax assets:
Accrued compensation$2,218 $5,742 
Net operating loss carryforwards18 61 
Depreciation5,360 4,365 
Tax credits15,180 15,079 
Operating lease liabilities4,567 5,807 
Capitalized R&D costs1,116 — 
Accruals and reserves558 643 
Total deferred tax assets29,017 31,697 
Valuation allowance(6,686)(5,755)
Total deferred tax assets, net of valuation allowance22,331 25,942 
Deferred tax liabilities:
Depreciation and amortization(16,899)(18,909)
Right of use assets(4,315)(5,579)
Investments(27,864)(29,619)
Total deferred tax liabilities(49,078)(54,107)
Net deferred tax liabilities
$(26,747)$(28,165)
The breakdown between deferred tax assets and liabilities is as follows:
 June 30, 
 20232022
(in thousands)
Long-term deferred tax assets$536 $592 
Long-term deferred tax liabilities(27,283)(28,757)
Net deferred tax liabilities$(26,747)$(28,165)

The Company’s valuation allowance related to deferred income taxes as reflected in the consolidated balance sheets was $6.7 million and $5.8 million as of June 30, 2023 and 2022, respectively. The change in valuation allowance for June 30, 2023 and 2022 was an increase of $0.9 million and a decrease of $35.7 million, respectively.

At June 30, 2023 and 2022, the Company provided a valuation allowance for its state research and development credit carryforward deferred tax assets of $6.7 million and $5.8 million, respectively, as it generated more state tax credits each year than it can utilize. The Company intends to maintain a valuation allowance equal to the state research and development credit carryforwards in excess of the state net deferred tax liabilities on all other state book/tax differences and net operating loss carryforward.

At June 30, 2021, the Company provided a valuation allowance mainly for the net operating loss, fixed asset and intangible asset related to deferred tax assets of the JV Company totaling $35.7 million. The valuation allowance related to the deferred tax assets of the JV Company was reduced to $0 at June 30, 2022 as a result of the deconsolidation of the JV Company in December 2021.

At June 30, 2023, the Company had federal research and development tax credit carryforwards of approximately $8.0 million. The federal tax credits begin to expire in 2039, if not utilized.  At June 30, 2023, the Company had state tax credit carryforwards of approximately $9.0 million, which carryforward indefinitely.
The Company has not provided for withholding taxes on the undistributed earnings of its foreign subsidiaries because it intends to reinvest such earnings indefinitely. However, we have recorded a deferred tax liability of $27.9 million at June 30, 2023 related to our investment in the JV Company. As of June 30, 2023, the cumulative amount of undistributed earnings of its foreign entities considered permanently reinvested is $374.0 million. The determination of the unrecognized deferred tax liability on these earnings is not practicable. Should the Company decide to remit this income to its Bermuda parent company in a future period, its provision for income taxes may increase materially in that period.
A reconciliation of the beginning and ending amount of unrecognized tax benefits from July 1, 2020 to June 30, 2023 is as follows:
 Year Ended June 30, 
 202320222021
(in thousands)
Balance at beginning of year$8,609 $7,645 $7,126 
Additions based on tax positions related to the current year804 1,121 677 
Reductions based on tax positions related to prior years(68)(40)(41)
Reductions due to lapse of applicable statute of limitations(10)(117)(117)
Balance at end of year$9,335 $8,609 $7,645 
At June 30, 2023, the total unrecognized tax benefits of $9.3 million included $6.8 million of unrecognized tax benefits that have been netted against the related deferred tax assets. The remaining $2.5 million of unrecognized tax benefits was recorded within long-term income tax payable on the Company's consolidated balance sheet as of June 30, 2023. The Company cannot reasonably estimate the timing and amount of potential cash settlements on the unrecognized tax benefits.
The total unrecognized tax benefits of $9.3 million at June 30, 2023 included $6.3 million that, if recognized, would reduce the effective income tax rate in future periods. It is reasonably possible that the Company will recognize approximately no reduction to its uncertain tax positions during the next twelve months.
The Company recognizes interest and penalties related to uncertain tax positions in income tax expense. To the extent accrued interest and penalties do not ultimately become payable, amounts accrued will be reduced and reflected as a reduction of the overall income tax provision in the period that such determination is made. The amount of interest and penalties accrued at June 30, 2023 was $0.3 million, of which $0.1 million was recognized in the year ended June 30, 2023. The amount of interest and penalties accrued at June 30, 2022 was $0.2 million, of which $32 thousand was recognized in the year ended June 30, 2022.

The Company files its income tax returns in the United States and in various foreign jurisdictions. The tax years 2004 to 2023 remain open to examination by U.S. federal and state tax authorities due to tax attribute carryovers. The tax years 2017 to 2023 remain open to examination by foreign tax authorities.

The Company's income tax returns are subject to examinations by the Internal Revenue Service and other tax authorities in various jurisdictions. In accordance with the guidance on the accounting for uncertainty in income taxes, the Company regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of its provision for income taxes. These assessments can require considerable estimates and judgments. If the Company's estimate of income tax liabilities proves to be less than the ultimate assessment, then a further charge to expense would be required. If events occur and the payment of these amounts ultimately proves to be unnecessary, the reversal of the liabilities would result in tax benefits being recognized in the period when the Company determines the liabilities are no longer necessary.

"U.S. Tax Cuts and Jobs Act", Enacted December 22, 2017

On December 22, 2017, the United States enacted tax legislation commonly known as the Tax Cuts and Jobs Act (“the Tax Act”), which significantly changed the existing U.S. tax laws, including, but not limited to, (1) a reduction in the corporate tax rate from 35% to 21%, (2) a move from a worldwide tax system toward a territorial system through a “participation exemption” deduction for certain foreign-source dividends, (3) eliminating the corporate alternative minimum tax (AMT) and changing how existing AMT credits can be realized, (4) bonus depreciation that allows for full expensing of qualified property, (5) creating a new limitation on deductible interest expense and (6) changing rules related to uses and limitations of net operating loss carryforwards created in tax years beginning after December 31, 2017.
The Company is not currently subject to the Base Erosion and Anti-Abuse (BEAT) tax, which is a tax imposed on certain entities who make payments to their non U.S. affiliates, where such payments reduce the U.S. tax base. The BEAT tax is imposed at a rate of 10% on Adjusted Taxable Income, excluding certain payments to foreign related entities. It is an incremental tax over and above the corporate income tax and is recorded as a period cost. It is possible that this tax could be applicable in future periods, which would cause an increase to the effective tax rate and cash taxes.

The Company is subject to U.S. research expense capitalization under IRC Section 174 and is eligible for the foreign derived intangible income (FDII) deductions under the 2017 U.S. Tax Cuts and Jobs Act. The IRC Section 174 research expense capitalization results in a timing difference which is amortizable over five years for domestic R&D expenditures and 15 years for foreign R&D expenditures. The FDII deduction results in a favorable permanent book-tax difference which is based on multiple factors including the amount of foreign sourced taxable income of U.S. corporations.

"U.S. Coronavirus Aid, Relief and Economic Security Act” (“CARES Act”), Enacted March 27, 2020

On March 27, 2020, the United States enacted the CARES Act, which made the changes to existing U.S. tax laws, including, but not limited to, (1) allowing U.S. federal net operating losses originated in the 2018, 2019 or 2020 tax years to be carried back five years to recover taxes paid based upon taxable income in the prior five years, (2) eliminated the 80% of taxable income limitation on net operating losses for the 2018, 2019 and 2020 tax years (the 80% limitation will be reinstated for tax years after 2020), (3) accelerating the refund of prior year alternative minimum tax credits, (4) modifying the bonus depreciation for qualified improvement property and (5) modifying the limitation on deductible interest expense.

As a result of the ability to carryback net operating losses from the June 2018 and June 2019 years to the June 2015 to June 2017 tax years, net operating losses which were previously tax-effected using the current 21% U.S. federal tax rate were revalued to the U.S. tax rates in effect for the June 2015 to June 2017 tax years due to the ability of receiving tax refunds for the taxes paid in these years. Accordingly, we reported a discrete tax benefit of $1.1 million in the third quarter of fiscal year 2020 related to the re-measurement of the net operating losses that could be realized via the new net operating loss carryback provisions.

“U.S. Consolidated Appropriations Act, 2021” (“CAA 2021”), Enacted December 27, 2020

On December 27, 2020, the United States enacted the Consolidated Appropriations Act, 2021, which made changes to existing U.S. tax laws. There was no material impact of the tax law changes included in the Consolidated Appropriations Act, 2021 to the Company.

“The American Rescue Plan Act of, 2021”, Enacted March 11, 2021

On March 11, 2021, the United States enacted the American Rescue Plan Act of 2021, which made changes to existing U.S. tax laws. There was no material impact of the tax law changes included in the American Rescue Plan Act of 2021 to the Company.

“The Chip and Science Act of 2022”, Enacted August 2, 2022

In August 2022 the U.S. enacted the Chip and Science Act of 2022 (the Chips Act). The Chips Act provides incentives to semiconductor chip manufacturers in the United States, including providing a 25% manufacturing investment credits for investments in semiconductor manufacturing property placed in service after December 31, 2022, for which construction begins before January 1, 2027. Property investments qualify for the 25% credit if, among other requirements, the property is integral to the operation of an advanced manufacturing facility, defined as having a primary purpose of manufacturing semiconductors or semiconductor manufacturing equipment. Currently, we are evaluating the impact of the Chips Act to us.

“The Inflation Reduction Act”, Enacted August 16, 2022

In August 2022 the United States enacted tax legislation through the Inflation Reduction Act (IRA). The IRA introduces a 15% corporate alternative minimum tax (CAMT) for corporations whose average annual adjusted financial statement income (AFSI) for any consecutive three-tax-year period preceding the applicable tax year exceeds $1 billion. The CAMT is effective for tax years beginning after 31 December 2022. The CAMT is currently not applicable to the Company.

Altera Litigation
v3.23.2
Segment and Geographic information
12 Months Ended
Jun. 30, 2023
Segment Reporting [Abstract]  
Segment and Geographic Information Segment and Geographic Information
The Company is organized as, and operates in, one operating segment: the design, development and supply of power semiconductor products for computing, consumer electronics, communication and industrial applications. The chief operating decision-makers are the Executive Chairman and the Chief Executive Officer. The financial information presented to the Company’s Executive Chairman and Chief Executive Officer is on a consolidated basis, accompanied by information about revenue by customer and geographic region, for purposes of evaluating financial performance and allocating resources. The Company has one business segment, and there are no segment managers who are held accountable for operations, operating results and plans for products or components below the consolidated unit level. Accordingly, the Company reports as a single operating segment.
The Company sells its products primarily to distributors in the Asia Pacific region, who in turn sell these products to end customers. Because the Company’s distributors sell their products to end customers which may have a global presence, revenue by geographical location is not necessarily representative of the geographical distribution of sales to end user markets.

In February 2023, the Company entered into a license agreement with a customer to license the Company’s proprietary SiC technology and to provide 24-months of engineering and development services for a total fee of $45 million.
The revenue by geographical location in the following tables is based on the country or region in which the products were shipped to: 
 Year Ended June 30, 
 202320222021
(in thousands)
Hong Kong$561,855 $630,238 $537,553 
China84,546 120,978 107,325 
South Korea9,168 11,802 5,497 
United States19,744 12,470 5,492 
Other countries16,008 2,064 1,035 
 $691,321 $777,552 $656,902 
 Year Ended June 30, 
 202320222021
 (in thousands)
Power discrete$458,795 $545,135 $482,718 
Power IC218,620 220,882 161,726 
Packaging and testing services3,979 11,535 12,458 
License and development services9,927 — — 
 $691,321 $777,552 $656,902 
Long-lived assets, net consisting of property, plant and equipment and land use rights, net, as well as operating lease right-of-use assets, net by geographical area are as follows:
 June 30,
 20232022
(in thousands)
China$114,822 $105,326 
United States263,083 232,731 
Other countries4,275 4,283 
 $382,180 $342,340 
v3.23.2
Restricted Net Assets
12 Months Ended
Jun. 30, 2023
Restrictions for Consolidated and Unconsolidated Subsidiaries [Abstract]  
Restricted Net Assets Restricted Net Assets Laws and regulations in China permit payments of dividends by the Company's subsidiaries in China only out of their retained earnings, if any, as determined in accordance with China accounting standards and regulations. Each China subsidiary is also required to set aside at least 10% of its after-tax profit, if any, based on China accounting standards each year to its statutory reserves until the cumulative amount of such reserves reaches 50% of its registered capital. As a result of these China laws and regulations, the Company's China subsidiaries are restricted in their abilities to transfer a portion of their net assets to the Company. As of June 30, 2023 and 2022, such restricted portion amounted to approximately $93.2 million and $92.4 million, or 10.5% and 10.8%, of our total consolidated net assets attributable to the Company, respectively. As the Company's China subsidiaries are not revenue generating operating units, the Company does not expect to repatriate funds in the form of dividends, loans or advances from its China subsidiaries for working capital and other funding purposes.
v3.23.2
Commitments and Contingencies
12 Months Ended
Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Purchase commitments
As of June 30, 2023 and 2022, the Company had approximately $127.5 million and $89.9 million, respectively, of outstanding purchase commitments primarily for purchases of semiconductor raw materials, wafers, spare parts, packaging and testing services and others.
As of June 30, 2023 and 2022, the Company had approximately $9.7 million, and $63.4 million, respectively, of commitments for the purchase of property and equipment.
Other commitments
See Notes 1, 7 and 8 to the Consolidated Financial Statements contained in this annual Report on Form 10-K for descriptions of commitments including Joint Venture, bank borrowings and leases.
Contingencies and indemnities

The Company has in the past, and may from time to time in the future, become involved in legal proceedings arising from the normal course of business activities.  The semiconductor industry is characterized by frequent claims and litigation, including claims regarding patent and other intellectual property rights as well as improper hiring practices. Irrespective of the validity of such claims, the Company could incur significant costs in the defense of such claims and suffer adverse effects on its operations.

As previously disclosed, U.S. Department of Justice (“DOJ”) commenced an investigation into the Company’s compliance with export control regulations relating to its business transactions with Huawei and its affiliates (“Huawei”), which were added to the “Entity List” by the DOC in May 2019. The Company is cooperating fully with federal authorities in the investigation. The Company has continued to respond to inquiries and requests from DOJ for documents and information relating to the investigation, and the matter is currently pending at DOJ, and DOJ has not provided the Company with any specific timeline or indication as to when the investigation will be concluded or resolved. In connection with this investigation, DOC previously requested the Company to suspend shipments of its products to Huawei. The Company complied with such request, and the Company has not shipped any product to Huawei after December 31, 2019. As part of this process and in response to DOC’s request, the Company provided certain documents and materials relating to the Company’s supply chain and shipment process to DOC, and DOC is currently reviewing this matter. DOC has not informed the Company of any specific timeline or schedule under which DOC will complete its review. Given the case is in still ongoing and neither DOJ nor DOC have provided the Company with any clear indication of the timing and schedule for the investigation, the Company cannot estimate the reasonably possible loss or range of loss that may occur. Also, the Company is unable to predict the duration, scope, result or related costs of the investigation, although the Company expects to incur additional professional fees as a result of this matter. In addition, the Company is unable to predict what, if any, further action that may be taken by the government in connection with the investigation, or what, if any, penalties, sanctions or remedial actions may be sought.

The Company is a party to a variety of agreements that it has contracted with various third parties. Pursuant to these agreements, the Company may be obligated to indemnify another party to such an agreement with respect to certain matters. Typically, these obligations arise in the context of contracts entered into by the Company, under which the Company customarily agrees to hold the other party harmless against losses arising from a breach of representations and covenants related to such matters as title to assets sold, certain intellectual property rights, specified environmental matters and certain income taxes. In these circumstances, payment by the Company is customarily conditioned on the other party making a claim pursuant to the procedures specified in the particular contract, which procedures typically allow the Company to challenge the other party's claim. Further, the Company's obligations under these agreements may be limited in time and/or amount, and in some
instances, the Company may have recourse against third parties for certain payments made by it under these agreements. The Company has not historically paid or recorded any material indemnifications, and no accrual was made at June 30, 2023 and 2022.

The Company has agreed to indemnify its directors and certain employees as permitted by law and pursuant to its Bye-laws, and has entered into indemnification agreements with its directors and executive officers. The Company has not recorded a liability associated with these indemnification arrangements, as it historically has not incurred any material costs associated with such indemnification obligations. Costs associated with such indemnification obligations may be mitigated by insurance coverage that the Company maintains. However, such insurance may not cover any, or may cover only a portion of, the amounts the Company may be required to pay. In addition, the Company may not be able to maintain such insurance coverage at reasonable cost, if at all, in the future.

Environmental matters

The Company is subject to various federal, state, local, and foreign laws and regulations governing environmental
matters, including the use, handling, discharge, and disposal of hazardous materials. The Company believes that it has been in material compliance with applicable environmental regulations and standards. Complying with current laws and regulations has not had a material adverse effect on the Company’s financial condition and results of operations. However, it is possible that additional environmental issues may arise in the future, which the Company cannot currently predict.
v3.23.2
Schedule II - Valuation and Qualifying Accounts
12 Months Ended
Jun. 30, 2023
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
Valuation and Qualifying Accounts
AllowanceAllowanceValuation Allowance
for Doubtfulfor Price for Deferred
Accounts AdjustmentsTax Assets
June 30, 2020$30 $30,092 $37,827 
Additions— 178,902 3,647 
Reductions— (196,579)— 
June 30, 2021$30 $12,415 $41,474 
Additions— 170,651 — 
Reductions— (164,335)(35,719)
June 30, 2022$30 $18,731 $5,755 
Additions— 165,543 931 
Reductions— (144,298)— 
June 30, 2023$30 $39,976 $6,686 
v3.23.2
The Company and Significant Accounting Policies (Policies)
12 Months Ended
Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Preparation Basis of PreparationThe consolidated financial statements include the accounts of the Company, its wholly-owned subsidiaries and a subsidiary in which it had a controlling interest until December 1, 2021. As of December 2, 2021, the Company ceased having control over this subsidiary. Therefore, the Company deconsolidated this subsidiary as of that date. Subsequently, the Company has accounted for it using the equity method of accounting. All intercompany account balances and transactions have been eliminated. The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”).
Risks and Uncertainties
Certain Significant Risks and Uncertainties Related to Outbreak of Coronavirus Disease 2019 (“COVID-19”)

During the first half of calendar year 2022, the Company's operations were negatively impacted by China’s zero-Covid policy that resulted in factory shutdowns and supply chain shortages, including the temporary suspension of our factory operations in Shanghai from April to June 2022. In December 2022, the Chinese government issued new guidelines easing some of its strict zero-COVID policies, including the relaxation of testing requirements and travel restrictions. During the three months ended March 31, 2023, China and other parts of the world in which we conduct our business have ended pandemic restriction and have largely returned to normal. In general, our business operations are no longer affected by the COVID-19 pandemic.
Risks and Uncertainties

The Company is subject to certain risks and uncertainties. The Company believes changes in any of the following areas could have a material adverse effect on the Company's future financial position or results of operations or cash flows: the macroeconomic condition and cyclical nature of the semiconductor industry; the timing and success of new product development, including market receptiveness, operation of in-house manufacturing facilities, litigation or claims against the Company based on intellectual property, patent, product regulatory or other factors, competition from other products, general economic conditions, the inability to attract and retain qualified employees, lack of control to the JV Company and ultimately to sustain profitable operations, risks associated with doing business in China, and ability to diversify products and develop digital business; the general state of the U.S., China and world economies; the loss of any of its larger customers; restrictions on the
Company’s ability to sell to foreign customers due to trade laws, regulations and requirements; disruptions of the supply chain of components needed for our products; inability to obtain additional financing; inability to meet certain debt covenants; fundamental changes in the technology underlying the Company’s products; successful and timely completion of product design efforts; and new product design introductions by competitors. Additional risks and uncertainties that the Company is unaware of, or that the Company currently believes are not material, may also become important factors that adversely affect its business.

The Company's revenue is limited by its ability to utilize wafer production and packaging and testing capacity from its in-house facilities and obtain adequate wafer supplies from third-party foundries. The Company entered into an agreement with the JV Company pursuant to which the JV Company agrees to provide the Company with a guaranteed supply of a fixed number of wafers until December 2023. Currently the Company's main third-party foundry is Shanghai Hua Hong Grace Electronic Company Limited, or HHGrace, located in Shanghai, China. HHGrace has been manufacturing wafers for the Company since 2002. HHGrace manufactured approximately 9.6%, 10.3% and 11.5% of the wafers used in the Company's products for the fiscal years ended June 30, 2023, 2022 and 2021, respectively. Although the Company believes that its volume of production allows the Company to secure favorable pricing and priority in allocation of capacity in its third-party foundries, if the foundries' capacities are constrained due to market demands, HHGrace, together with other foundries from which the Company purchases wafers, may not be willing or able to satisfy all of the Company's manufacturing requirements on a timely basis and/or at favorable prices. In addition, manufacturing facilities' capacity affects the Company's gross margin because the Company has certain fixed costs associated with its Oregon Fab as well as in-house packaging and testing facilities. If the Company fails to utilize its manufacturing facilities' capacity at a desirable level, its financial condition and results of operations will be adversely affected.
Use of Estimates
Use of Estimates
The preparation of the consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses. To the extent there are material differences between these estimates and actual results, the Company's consolidated financial statements will be affected. On an ongoing basis, the Company evaluates the estimates, judgments and assumptions including those related to stock rotation returns, price adjustments, allowance for doubtful accounts, inventory reserves, warranty accrual, income taxes, leases, share-based compensation, recoverability of and useful lives for property, plant and equipment and intangible assets, as well as the economic implications of the COVID-19 pandemic.
Foreign Currency Transactions and Translation
Foreign Currency Transactions and Translation
Most of the Company's principal subsidiaries use U.S. dollars as their functional currency because their transactions are primarily conducted and settled in U.S. dollars. All of their revenues and a significant portion of their operating expenses are denominated in U.S. dollars. The functional currencies for the Company's in-house packaging and testing facilities in China are U.S. dollars, and a majority of their capital expenditures are denominated in U.S. dollars. Foreign currency transactions are translated into the functional currencies using the exchange rates prevailing at the dates of the transactions. Foreign exchange gains and losses, resulting from the settlement of such transactions and from the re-measurement of monetary assets and liabilities denominated in foreign currencies using exchange rates at balance sheet date and non-monetary assets and liabilities using historical exchange rates, are recognized in the consolidated statements of operations.
For the Company's subsidiaries which use the local currency as their functional currency, their results and financial position are translated into U.S. dollars using exchange rates at balance sheet dates for assets and liabilities and using average exchange rates for income and expenses items. The resulting translation differences are presented as a separate component of accumulated other comprehensive income (loss) and noncontrolling interest in the consolidated statements of equity.
Cash and Cash Equivalents, Restricted Cash
Cash, Cash Equivalents and Restricted Cash
Cash and cash equivalents primarily consist of cash on hand and short-term bank deposits with original maturities of three months or less. Cash equivalents are highly liquid investments with stated maturities of three months or less as of the dates of purchase. The carrying amounts reported for cash and cash equivalents are considered to approximate fair values based upon their short maturities.

Cash and cash equivalents are maintained with reputable major financial institutions. If, due to current economic conditions or other factors, one or more of the financial institutions with which the Company maintains deposits fails, the Company's cash and cash equivalents may be at risk. Deposits with these banks may exceed the amount of insurance provided on such deposits; however, these deposits typically may be redeemed upon demand and, therefore, bear minimal risk.
The Company maintains restricted cash in connection with cash balances temporarily restricted for regular business operations. These balances have been excluded from the Company’s cash and cash equivalents balance and are classified as restricted cash in the Company’s consolidated balance sheets. As of June 30, 2023 and 2022, the amount of restricted cash was $0.4 million and $0.3 million, respectively.
Accounts Receivable Accounts Receivable, netThe allowance for doubtful accounts is based on assessment of the collectability of accounts receivable from customers. The Company reviews the allowance by considering factors such as historical collection experience, credit quality, age of the accounts receivable balances and current economic conditions that may affect a customer's ability to pay. The Company writes off a receivable and charges against its recorded allowance when it has exhausted its collection efforts without success.
Fair Value Measurements
Fair Value Measurements
    Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value, which are the following:
Level 1 - Quoted prices in active markets for identical assets or liabilities.
Level 2 - Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
Fair Value of Financial Instruments
Fair Value of Financial Instruments
The fair value of cash equivalents is based on observable market prices and have been categorized in Level 1 in the fair value hierarchy. Cash equivalents consist primarily of short-term bank deposits. The carrying values of financial instruments such as cash and cash equivalents, accounts receivable and accounts payable approximate their carrying values due to their short-term maturities. The carrying value of the Company's debt is considered a reasonable estimate of fair value which is estimated by considering the current rates available to the Company for debt of the same remaining maturities, structure and terms of the debts.
Inventories Inventories The Company carries inventories at the lower of cost (determined on a first-in, first-out basis) or net realizable value. Cost includes semiconductor wafer and raw materials, labor, depreciation expenses and other manufacturing expenses and overhead, and packaging and testing fees paid to third parties if subcontractors are used. Valuation of inventories are based on the Company's periodic review of inventory quantities on hand as compared with its sales forecasts, historical usage, aging of inventories, production yield levels and current product selling prices. If actual market conditions are less favorable than those forecasted by management, additional future inventory write-downs may be required that could adversely affect the Company's operating results. Adjustments to inventory once established are not reversed until the related inventory has been sold or scrapped. If actual market conditions are more favorable than expected and the products that have previously been written down are sold, our gross margin would be favorably impacted.
Property, Plant and Equipment
Property, Plant and Equipment
Property, plant and equipment are stated at historical cost less accumulated depreciation. Historical cost includes expenditures that are directly attributable to the acquisition of the items and the costs incurred to make the assets ready for their intended use.
Depreciation is provided for on a straight-line basis over the estimated useful lives of the related assets as follows:
 
Building and building improvements
20 years
Manufacturing machinery and equipment
7 to 10 years
Equipment and tooling
3 to 5 years
Computer hardware and software
3 to 5 years
Office furniture and equipment
3 to 5 years
Leasehold improvements
2 to 15 years
Vehicle
5 years

Equipment and construction in progress represent equipment received but the necessary installation has not been fully performed or building construction and leasehold improvements have been started but not yet completed. Equipment and construction in progress are stated at cost and transferred to respective asset class when fully completed and ready for their intended use.
Internal-use software development costs are capitalized to the extent that the costs are directly associated with the development of identifiable and unique software products controlled by the Company that will probably generate economic benefits beyond one year. Costs incurred during the application development stage are required to be capitalized. The application development stage is characterized by software design and configuration activities, coding, testing and installation. Training costs and maintenance are expensed as incurred, while upgrades and enhancements are capitalized if it is probable that such expenditures will result in additional functionality. Costs include employee costs incurred and fees paid to outside consultants for the software development and implementation. Internally developed software is amortized over its estimated useful life of three to five years starting from the date when it is ready for its intended use.
Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognized as selling, general and administrative expenses in the consolidated statements of operations. Costs of maintenance and repairs that do not improve or extend the lives of the respective assets are expensed as incurred.
Government Grants Government GrantsThe Company occasionally receives government grants that provide financial assistance for certain eligible expenditures in China. These grants include reimbursements on interest expense on bank borrowings, payroll tax credits, credit for property, plant and equipment in a particular geographical location, employment credits as well as business expansion credits. Government grants are not recognized until there is reasonable assurance that the Company will comply with the conditions attaching to it, and that the grant will be received. The Company records such grants either as a reduction of the related expense, a reduction of the cost of the related asset, or as other income depending upon the nature of the grant.
Impairment of Long-Lived Assets
Long-lived Assets

The Company reviews all long-lived assets whenever events or changes in circumstance indicate that these assets may not be recoverable. When evaluating long-lived assets, if the Company concludes that the estimated undiscounted cash flows attributable to the assets are less than their carrying value, the Company recognizes an impairment loss based on the excess of the carrying amount of the assets over their respective fair values, which could adversely affect our results of operations.
Revenue Recognition
Revenue Recognition

The Company determines revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract; and (5) recognition of revenue when, or as, a performance obligation is satisfied. The Company recognizes product revenue at a point in time when product is shipped to the customer, as determined by the agreed upon shipping terms, net of estimated stock rotation returns and price adjustments that it
expects to provide to certain distributors. The Company presents revenue net of sales taxes and any similar assessments. Our standard payment terms range from 30 to 60 days.

The Company sells its products primarily to distributors, who in turn sell the products globally to various end customers. The Company allows stock rotation returns from certain distributors. Stock rotation returns are governed by contract and are limited to a specified percentage of the monetary value of products purchased by distributors during a specified period. The Company records an allowance for stock rotation returns based on historical returns, current expectations, and individual distributor agreements. The Company also provides special pricing to certain distributors, primarily based on volume, to encourage resale of the Company's products. Allowance for price adjustments is recorded against accounts receivable and the provision for stock rotation rights is included in accrued liabilities on the consolidated balance sheets.

The Company's performance obligations relate to contracts with a duration of less than one year. The Company elected to apply the practical expedient provided in ASC 606, “Revenue from Contracts with Customers”. Therefore, the Company is not required to disclose the aggregate amount of transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period.

The Company recognizes the incremental direct costs of obtaining a contract, which consist of sales commissions, when control over the products they relate to transfers to the customer. Applying the practical expedient, the Company recognizes commissions as expense when incurred, as the amortization period of the commission asset the Company would have otherwise recognized is less than one year.

Packaging and testing services revenue is recognized at a point in time upon shipment of serviced products to the customer.

License and Development Services Revenue Recognition
In February 2023, the Company entered into a license agreement with a customer to license the Company’s proprietary SiC technology and to provide 24-months of engineering and development services for a total fee of $45 million, consisting of an upfront fee of $18 million and $6.8 million paid to the Company in March 2023 and July 2023, respectively, with the remaining amount to be paid upon the achievement of specified engineering services and product milestones. The license and development fee is determined to be one performance obligation and is recognized over the 24 months when the Company performs the engineering and development services. The Company uses the input method to measure progression, representing a faithful depiction of the transfer of services. During the fiscal year ended June 30, 2023, the Company recorded $9.9 million of license and development revenue. The amount of contract liability is recorded as deferred revenue on the consolidated balance sheets. In addition, the Company also entered an accompanying supply agreement to provide limited wafer supply to the customer.
Leases
Leases

The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets, current operating lease liabilities and long-term operating lease liabilities on the Company's consolidated balance sheets. Finance leases are included in property, plant and equipment, finance lease liabilities and long-term finance leases liabilities on the consolidated balance sheets.
Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. The Company determined its incremental borrowing rate based on the information available at the lease commencement date. The operating lease ROU assets also include any lease payments made and exclude lease incentives. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. Operating lease expense is generally recognized on a straight-line basis over the lease term. Variable lease payments are expensed as incurred and are not included within the operating lease ROU asset and lease liability calculation. The Company does not record leases on the consolidated balance sheet with a term of one year or less. The Company elected to combine its lease and non-lease components as a single lease component for all asset classes.
Product Warranty
Product Warranty

The Company provides a standard one-year warranty for the products from the date of purchase by the end customers. The Company accrues for estimated warranty costs at the time revenue is recognized. The Company's warranty obligation is affected by product failure rates, labor and material costs for replacing defective parts, related freight costs for failed parts and other quality assurance costs. The Company monitors its product returns for warranty claims and maintains warranty reserves based on historical experiences and anticipated warranty claims known at the time of estimation.
Shipping and Handling Costs
Shipping and Handling Costs
Shipping and handling costs are included in cost of goods sold.
Research and Development Research and Development Research and development costs are expensed as incurred.
Provision for Income Taxes
Provision for Income Taxes

Income tax expense or benefit is based on income or loss before taxes. Deferred tax assets and liabilities are recognized principally for the expected tax consequences of temporary differences between the tax basis of assets and liabilities and their reported amounts.

The Company is subject to income taxes in a number of jurisdictions. Significant judgment is required in determining the worldwide provision for income taxes. There are many transactions and calculations for which the ultimate tax determination is uncertain during the ordinary course of business. The Company establishes accruals for certain tax contingencies based on estimates of whether additional taxes may be due. While the final tax outcome of these matters may differ from the amounts that were initially recorded, such differences will impact the income tax and deferred tax provisions in the period in which such determination is made.

Significant management judgment is also required in determining whether deferred tax assets will be realized in full or in part. When it is more likely than not that all or some portion of specific deferred tax assets such as net operating losses or research and experimentation tax credit carryforwards will not be realized, a valuation allowance must be established for the amount of the deferred tax assets that cannot be realized. The Company considers all available positive and negative evidence on a jurisdiction-by-jurisdiction basis when assessing whether it is more likely than not that deferred tax assets are recoverable. The Company considers evidence such as our past operating results, the existence of cumulative losses in recent years and our forecast of future taxable income. The Company has concluded that it should report a full valuation allowance on its state research and development (R&D) tax credit carryforwards as the Company annually generates more state R&D tax credits than it could use based on its forecasts.

The Financial Accounting Standards Board (FASB), issued guidance which clarifies the accounting for income taxes by prescribing a minimum probability threshold that a tax position must meet before a financial statement benefit is recognized. The minimum threshold is defined as a tax position that is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. The tax benefit to be recognized is measured as the largest amount of benefit that is greater than fifty percent likely to be realized upon ultimate settlement. Although the guidance on the accounting for uncertainty in income taxes prescribes the use of a recognition and measurement model, the determination of whether an uncertain tax position has met those thresholds will continue to require significant judgment by management. If the ultimate resolution of tax uncertainties is different from what is currently estimated, a material impact on income tax expense could result.

The Company's provision for income taxes is subject to volatility and could be adversely impacted by changes in earnings or tax laws and regulations in various jurisdictions. The Company is subject to the continuous examination of our income tax returns by the Internal Revenue Service and other tax authorities. The Company regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of our provision for income taxes. To the extent that the final tax outcome of these matters is different from the amounts recorded, such differences will impact the provision for income taxes in the period in which such determination is made. The provision for income taxes includes the impact of changes to reserves, as well as the related net interest and penalties.
Share-based Compensation Expense
Share-based Compensation Expense

The Company maintains an equity-settled, share-based compensation plan to grant restricted share units and stock options. The Company recognizes expense related to share-based compensation awards that are ultimately expected to vest based on estimated fair values on the date of grant. The fair value of restricted share units is based on the fair value of the Company's common share on the date of grant. For restricted stock awards subject to market conditions, the fair value of each restricted stock award is estimated at the date of grant using the Monte-Carlo pricing model. The fair value of stock options is estimated on the date of grant using the Black-Scholes option valuation model. Share-based compensation expense is recognized on the accelerated attribution basis over the requisite service period of the award, which generally equals the vesting period. The Black-Scholes option valuation model requires the input of subjective assumptions, including the expected term and stock price volatility. In addition, judgment is also required in estimating the number of stock-based awards that are expected to be forfeited. Forfeitures are estimated based on historical experience at the time of grant. Changes in estimated forfeitures are
recognized in the period of change and impact the amount of stock compensation expenses to be recognized in future periods, which could be material if actual results differ significantly from estimates.The Employee Share Purchase Plan (the “ESPP”) is accounted for at fair value on the date of grant using the Black-Scholes option valuation model.
Advertising
Advertising

Advertising expenditures are expensed as incurred. Advertising expense was $0.5 million, $0.2 million and $0.4 million in the fiscal years ended June 30, 2023, 2022, and 2021, respectively.
Comprehensive Income (loss) Comprehensive Income (Loss) Comprehensive income (loss) is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. The Company's accumulated other comprehensive income (loss) consists of cumulative foreign currency translation adjustments.
Recent Accounting Pronouncements
Recent Accounting Pronouncements
Recently Issued Accounting Standards not yet adopted

In September 2022, the FASB issued ASU No. 2022-04, Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations. This ASU was issued in response to requests from financial statement users for increased transparency surrounding the use of supplier finance programs. The amendments in ASU 2022-04 require that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The amendments in this ASU do not affect the recognition, measurement, or financial statement presentation of obligations covered by supplier finance programs. The amendments in this ASU are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. The Company is currently evaluating the impact of adopting this guidance.
Recently Adopted Accounting Standards

In November 2021, the FASB issued Accounting Standards Update (ASU) No. 2021-10, Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance. This ASU requires business entities to make annual disclosures about transactions with a government they account for by analogizing to a grant or contribution accounting model under ASC 958-605. The adoption of ASU 2021-10 in the fiscal year ended June 30, 2023 on a prospective basis had no impact on the Company's Consolidated Financial Statements.

In August 2020, the FASB issued ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which, among other things, provides guidance on how to account for contracts on an entity’s own equity. This ASU simplifies the accounting for certain financial instruments with characteristics of liabilities and equity. Specifically, the ASU eliminated the need to assess whether a contract on the entity’s own equity (1) permits settlement in unregistered shares, (2) whether counterparty rights rank higher than shareholder’s rights, and (3) whether collateral is required. In addition, the ASU requires incremental disclosure related to contracts on the entity’s own equity and clarifies the treatment of certain financial instruments accounted for under this ASU on earnings per share. The adoption of ASU 2020-06 had no impact on the Company's Consolidated Financial Statements.
v3.23.2
The Company and Significant Accounting Policies (Tables)
12 Months Ended
Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Property, Plant and Equipment Depreciation is provided for on a straight-line basis over the estimated useful lives of the related assets as follows:  
Building and building improvements
20 years
Manufacturing machinery and equipment
7 to 10 years
Equipment and tooling
3 to 5 years
Computer hardware and software
3 to 5 years
Office furniture and equipment
3 to 5 years
Leasehold improvements
2 to 15 years
Vehicle
5 years
Property, plant and equipment, net
 
June 30,  
 20232022
(in thousands)
Land$4,877 $4,877 
Building and building improvements26,478 16,691 
Manufacturing machinery and equipment398,757 287,574 
Equipment and tooling32,737 28,052 
Computer equipment and software49,890 46,758 
Office furniture and equipment3,087 2,820 
Leasehold improvements38,787 35,254 
 554,613 422,026 
Less: accumulated depreciation(272,503)(233,340)
 282,110 188,686 
Equipment and construction in progress75,721 129,980 
Property, plant and equipment, net$357,831 $318,666 
Schedule of Finite-Lived Intangible Assets
Intangible assets, net
 
June 30,  
 20232022
(in thousands)
Patents and technology rights$18,037 $18,037 
Trade name268 268 
Customer relationships1,150 1,150 
19,455 19,455 
Less: accumulated amortization(12,959)(9,674)
6,496 9,781 
Goodwill269 269 
Intangible assets, net$6,765 $10,050 
v3.23.2
Equity Method Investment in Equity Investee (Tables)
12 Months Ended
Jun. 30, 2023
Discontinued Operations and Disposal Groups [Abstract]  
Schedule of deconsolidation The gain on deconsolidation of the JV Company was calculated as follows:
(in thousands)
Cash received for sales of shares in the JV Company
$16,924 
Fair value of retained equity method investment
393,124 
Carrying amount of non-controlling interest
143,889 
Cumulative translation adjustment removal
1,793 
Carrying amount of net assets of the JV Company at December 1, 2021
(156,637)
Gain on deconsolidation of the JV Company
$399,093 
The net loss associated with these sales of JV Company equity interest held by the Company were recorded in the fiscal year ended June 30, 2022 as follows:

(in thousands)
Gain on 1.1% equity interest sold
$475 
Loss on diluted equity interest from issuance of shares under the employee equity incentive plan
(8,116)
Gain on 7.82% equity interest sol
4,501 
Loss on changes on equity interest of the JV Company, net
$(3,140)
Summarized financial information of joint venture
The following table presents summarized financial information for the JV Company as of and for the period from April 1, 2022 through March 31, 2023 and December 2, 2021 through March 31, 2022, using lag reporting (in thousands):

As of March 31, 2023As of March 31, 2022
Current assets$122,324 $198,323 
Non-current assets$333,165 $364,777 
Current liabilities$122,340 $251,988 
Non-current liabilities$36,525 $76,207 
For the period of April 1, 2022 to March 31, 2023For the period of December 2, 2021 to March 31, 2022
Revenue$178,974 $68,972 
Gross loss (income)$(4,502)$870 
Operating expenses$5,939 $2,280 
Net loss$4,906 $6,197 
v3.23.2
Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited (Tables)
12 Months Ended
Jun. 30, 2023
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following table presents the calculation of basic and diluted net income per share attributable to common shareholders:
 Year Ended June 30,  
 202320222021
(in thousands, except per share data)
Numerator:
Net income attributable to Alpha and Omega Semiconductor Limited$12,364 $453,163 $58,116 
Denominator:
Basic:
Weighted average number of common shares used to compute basic net income per share27,552 26,764 25,786 
Diluted:
Weighted average number of common shares used to compute basic net income per share27,552 26,764 25,786 
Effect of potentially dilutive securities:
Stock options, RSUs and ESPP shares1,976 1,439 1,486 
Weighted average number of common shares used to compute diluted net income per share29,528 28,203 27,272 
Net income per share attributable to Alpha and Omega Semiconductor Limited:
Basic$0.45 $16.93 $2.25 
Diluted$0.42 $16.07 $2.13 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following potential dilutive securities were excluded from the computation of diluted net income per share as their effect would have been anti-dilutive:
 Year Ended June 30,  
 202320222021
(in thousands)
Employee stock options and RSUs310 277 193 
ESPP309 21 71 
Total potential dilutive securities619 298 264 
v3.23.2
Concentration of Credit Risk and Significant Customers (Tables)
12 Months Ended
Jun. 30, 2023
Risks and Uncertainties [Abstract]  
Schedules of Concentration of Risk, by Risk Factor
Summarized below are individual customers whose revenue or accounts receivable balances were 10% or higher than the respective total consolidated amounts:
   Year Ended June 30,
Percentage of revenue  2023 2022 2021
Customer A  21.6 % 24.6 % 28.7 %
Customer B  35.6 % 39.7 % 35.4 %
Customer D  14.0 % * *
   June 30,
Percentage of accounts receivable  2023 2022
Customer A  15.3 % 24.6 %
Customer B  17.6 % 36.4 %
Customer C  13.3 % *
Customer D30.9 %12.0 %
* Less than 10%
v3.23.2
Balance Sheet Components (Tables)
12 Months Ended
Jun. 30, 2023
Balance Sheet Related Disclosures [Abstract]  
Schedule of Accounts, Notes, Loans and Financing Receivable
Accounts receivable, net
 
June 30,  
 20232022
(in thousands)
Accounts receivable$62,426 $84,442 
Less: Allowance for price adjustments(39,976)(18,731)
Less: Allowance for doubtful accounts(30)(30)
Accounts receivable, net$22,420 $65,681 
Schedule of Inventory, Current
Inventories
 
June 30,
 20232022
(in thousands)
Raw materials$86,620 $67,960 
Work in-process69,426 80,720 
Finished goods27,201 9,360 
 $183,247 $158,040 
Schedule of Other Current Assets
Other current assets
 
June 30,
 20232022
(in thousands)
VAT receivable$275 $737 
Other prepaid expenses3,863 3,954 
Prepaid insurance4,162 2,590 
Prepaid maintenance1,697 826 
Prepayments to supplier10,689 257 
Prepaid income tax707 2,086 
Interest receivable135 25 
Other receivables1,138 745 
 $22,666 $11,220 
Property, Plant and Equipment Depreciation is provided for on a straight-line basis over the estimated useful lives of the related assets as follows:  
Building and building improvements
20 years
Manufacturing machinery and equipment
7 to 10 years
Equipment and tooling
3 to 5 years
Computer hardware and software
3 to 5 years
Office furniture and equipment
3 to 5 years
Leasehold improvements
2 to 15 years
Vehicle
5 years
Property, plant and equipment, net
 
June 30,  
 20232022
(in thousands)
Land$4,877 $4,877 
Building and building improvements26,478 16,691 
Manufacturing machinery and equipment398,757 287,574 
Equipment and tooling32,737 28,052 
Computer equipment and software49,890 46,758 
Office furniture and equipment3,087 2,820 
Leasehold improvements38,787 35,254 
 554,613 422,026 
Less: accumulated depreciation(272,503)(233,340)
 282,110 188,686 
Equipment and construction in progress75,721 129,980 
Property, plant and equipment, net$357,831 $318,666 
Schedule of Other Assets, Noncurrent
Other long-term assets
June 30,  
 20232022
(in thousands)
Prepayments for property and equipment$1,717 $6,890 
Investment in privately held companies100 100 
Customs deposit 931 1,708 
Deposit with supplier12,290 6,396 
Other long-term deposits37 18 
Office leases deposits1,274 1,012 
Other3,354 1,553 
 $19,703 $17,677 
Schedule of Finite-Lived Intangible Assets
Intangible assets, net
 
June 30,  
 20232022
(in thousands)
Patents and technology rights$18,037 $18,037 
Trade name268 268 
Customer relationships1,150 1,150 
19,455 19,455 
Less: accumulated amortization(12,959)(9,674)
6,496 9,781 
Goodwill269 269 
Intangible assets, net$6,765 $10,050 
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense
Estimated future minimum amortization expense of intangible assets is as follows (in thousands):
Year ending June 30,
2024$3,249 
20253,247 
$6,496 
Schedule of Accrued Liabilities Accrued liabilities
 
June 30,  
 20232022
(in thousands)
Accrued compensation and benefits$15,627 $34,681 
Warranty accrual1,674 2,650 
Stock rotation accrual5,588 4,798 
Accrued professional fees2,458 2,659 
Accrued inventory1,597 2,491 
Accrued facilities related expenses2,327 2,421 
Accrued property, plant and equipment6,402 20,485 
Other accrued expenses4,401 5,159 
Customer deposit38,082 40,578 
ESPP payable1,377 971 
 $79,533 $116,893 
Short-term customer deposits are payments received from customers for securing future product shipments. As of June 30, 2023, $13.5 million were from Customer A and $9.2 million were from Customer B, and $15.4 million were from other customers. As of June 30, 2022, $12.5 million were from Customer A and $16.2 million were from Customer B, and $11.9 million were from other customers.
Schedule of Product Warranty Liability
The activity in the warranty accrual, included in accrued liabilities is as follows:
Year Ended June 30,
202320222021
(in thousands)
Beginning balance$2,650 $2,795 $709 
Addition3,666 1,127 2,443 
Utilization(4,642)(1,272)(357)
Ending balance$1,674 $2,650 $2,795 
Stock Rotation Accrual The activity in the stock rotation accrual, included in accrued liabilities is as follows:
Year Ended June 30,
202320222021
(in thousands)
Beginning balance$4,798 $3,917 $3,358 
Addition13,950 5,817 4,742 
Utilization(13,160)(4,936)(4,183)
Ending balance$5,588 $4,798 $3,917 
Schedule of Other Long-Term Liabilities
Other long-term liabilities
 
June 30,  
 20232022
(in thousands)
Customer deposits $46,393 $70,301 
Computer software liabilities4,644 8,302 
Other long-term liabilities$51,037 $78,603 
    Customer deposits are payments received from customers for securing future product shipments. As of June 30, 2023, $21.0 million were from Customer A and $11.7 million were from Customer B, and $13.7 million were from other customers. As of June 30, 2022, $34.5 million were from Customer A and $21.9 million were from Customer B and $13.9 million were from other customers.
v3.23.2
Debt (Tables)
12 Months Ended
Jun. 30, 2023
Debt Disclosure [Abstract]  
Fiscal Year Maturity Schedule
At June 30, 2023, maturities of short-term debt and long-term debt were as follows (in thousands):

Year ending June 30,
2024$11,472 
202511,664 
202611,871 
202714,344 
2028536 
Total principal of debt49,887 
Less: debt issuance costs(93)
Total principal of debt, less debt issuance costs$49,794 

Short-term DebtLong-term DebtTotal
Principal amount$11,472 $38,415 $49,887 
Less: debt issuance costs(38)(55)(93)
Total debt, less debt issuance costs$11,434 $38,360 $49,794 
v3.23.2
Leases (Tables)
12 Months Ended
Jun. 30, 2023
Leases [Abstract]  
Schedule of Operating and Finance Lease Expense
The components of the Company’s operating and finance lease expenses are as follows for the years presented (in thousands):

Fiscal Year Ended June 30, 2023Fiscal Year Ended June 30, 2022
Operating leases:
     Fixed rent expense$5,779 $6,262 
     Variable rent expense1,014 946 
Finance lease:
     Amortization of equipment522 908 
     Interest306 976 
Short-term leases:
     Short-term lease expenses400 205 
               Total lease expenses$8,021 $9,297 
Supplemental balance sheet information related to the Company’s operating and finance leases is as follows (in thousands, except lease term and discount rate):

June 30, 2023June 30, 2022
Operating Leases:
     ROU assets associated with operating leases$24,349 $23,674 
Finance Lease:
     Property, plant and equipment, gross$5,133 $4,831 
     Accumulated depreciation(657)(136)
          Property, plant and equipment, net$4,476 $4,695 
Weighted average remaining lease term (in years)
     Operating leases6.577.42
     Finance lease4.255.00
Weighted average discount rate
     Operating leases4.67 %4.27 %
     Finance lease7.51 %4.76 %

Supplemental cash flow information related to the Company’s operating and finance lease is as follows (in thousands):

Fiscal Year Ended June 30, 2023Fiscal Year Ended June 30, 2022
Cash paid from amounts included in the measurement of lease liabilities:
     Operating cash flows from operating leases$5,945 $6,480 
     Operating cash flows from finance lease$306 $976 
     Financing cash flows from finance lease$810 $4,176 
Non-cash investing and financing information:
     Operating lease right-of-use assets obtained in exchange for lease obligations$5,579 $5,852 
Schedule of Operating Lease Liability Maturities
Future minimum lease payments are as follows as of June 30, 2023 (in thousands):

Operating LeasesFinance Leases
2024$5,452 $1,144 
20254,623 1,144 
20263,807 1,144 
20273,647 1,145 
20283,317 191 
Thereafter8,303 — 
Total minimum lease payments29,149 4,768 
Less amount representing interest(4,222)(685)
Total lease liabilities$24,927 $4,083 
Schedule of Finance Lease Liability Maturities
Future minimum lease payments are as follows as of June 30, 2023 (in thousands):

Operating LeasesFinance Leases
2024$5,452 $1,144 
20254,623 1,144 
20263,807 1,144 
20273,647 1,145 
20283,317 191 
Thereafter8,303 — 
Total minimum lease payments29,149 4,768 
Less amount representing interest(4,222)(685)
Total lease liabilities$24,927 $4,083 
v3.23.2
Share-based Compensation (Tables)
12 Months Ended
Jun. 30, 2023
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Summary of Stock Option Activities
The following table summarizes the Company's stock option activities:
Weighted
WeightedAverage
AverageRemaining
Number ofExercise PriceContractual Aggregate
SharesPer ShareTerm (in years)Intrinsic Value
Outstanding at June 30, 2020643,978 $8.79 2.89
Granted— $— 
Exercised(156,103)$11.31 $1,272,291 
Canceled or forfeited— $— 
Outstanding at June 30, 2021487,875 $7.99 2.32
Granted— $— 
Exercised(98,000)$9.15 $3,936,675 
Canceled or forfeited— $— 
Outstanding at June 30, 2022389,875 $7.70 1.53
Granted— $— 
Exercised(65,500)$8.42 $1,442,646 
Canceled or forfeited(5,000)$9.19 
Outstanding at June 30, 2023319,375 $7.53 0.72$8,071,631 
Options vested and expected to vest319,375 $7.53 0.72$8,071,631 
Exercisable at June 30, 2023319,375 $7.53 0.72$8,071,631 
Restricted Stock Units Activity
The following table summarizes the Company's TRSU activities:
 
 Number of Restricted Stock
Units
Weighted Average
Grant Date Fair
Value Per Share
Weighted Average
Remaining
Recognition
Period (Years)
Aggregate Intrinsic Value
Nonvested at June 30, 2020932,138 $11.36 1.66$10,141,661 
Granted722,873 $29.85 
Vested(567,087)$15.70 
Forfeited(34,400)$14.88 
Nonvested at June 30, 20211,053,524 $21.60 1.73$32,016,594 
Granted597,381 $45.83 
Vested(410,670)$20.54 
Forfeited(70,626)$26.79 
Nonvested at June 30, 20221,169,609 $34.03 1.73$38,994,764 
Granted714,080 $27.70 
Vested(451,549)$28.84 
Forfeited(47,075)$33.40 
Nonvested at June 30, 20231,385,065 $32.48 1.73$45,430,132 
The following table summarizes the Company’s PRSU activities:
Number of Performance-based Restricted Stock
Units
Weighted Average
Grant Date Fair
Value Per Share
Weighted Average
Remaining
Recognition
Period (Years)
Aggregate Intrinsic Value
Nonvested at June 30, 2020342,775 $12.38 1.60$3,729,392 
Granted165,500 $36.27 
Vested(148,211)$14.24 
Forfeited(6,240)$17.23 
Nonvested at June 30, 2021353,824 $22.69 1.74$10,752,711 
Granted194,000 $48.65 
Vested(151,199)$19.44 
Forfeited(7,250)$40.33 
Nonvested at June 30, 2022389,375 $36.56 1.85$12,981,763 
Granted264,214 $25.70 
Vested(116,132)$30.54 
Forfeited(10,743)$48.65 
Nonvested at June 30, 2023526,714 $32.19 1.78$17,276,219 
Schedule of Nonvested Share Activity
The following table summarizes the Company’s MSUs activities:
Number of Performance-based Restricted Stock
Units
Weighted Average
Grant Date Fair
Value Per Share
Weighted Average
Remaining
Recognition
Period (Years)
Aggregate Intrinsic Value
Nonvested at June 30, 20201,290,000 $5.17 3.88$14,035,200 
Forfeited(50,000)$5.17 
Nonvested at June 30, 20211,240,000 $5.17 3.84$37,683,600 
Granted1,022,000 $48.44 
Forfeited(56,000)$9.81 
Nonvested at June 30, 20222,206,000 $25.10 3.83$73,548,040 
Vested(90,000)$5.17 
Forfeited(8,000)$48.44 
Nonvested at June 30, 20232,108,000 $25.86 2.96$69,142,400 
Employee Stock Purchase Plan, Valuation Assumptions
The ESPP is compensatory and results in compensation expense. The fair values of common shares to be issued under the ESPP were determined using the Black-Scholes option pricing model with the following assumptions:
Year Ended June 30,
202320222021
Volatility rate
64.0% - 70.5%
66.4% - 69.9%
63.1% - 68.5%
Risk-free interest rate
4.5% - 4.6%
0.3% - 2.1%
0.1% - 0.2%
Expected term1.3 years1.3 years1.3 years
Dividend yield—%—%—%
Share-based Compensation, Allocation of Recognized Period Costs
Share-based Compensation Expenses
The total share-based compensation expense related to TRSU, PSUs, MSUs, stock options and ESPP described above, recognized in the consolidated statements of operations for the years presented was as follows:
Year Ended June 30,
202320222021
(in thousands)
Cost of goods sold$5,851 $5,125 $1,756 
Research and development9,437 7,049 5,352 
Selling, general and administrative22,200 19,150 8,216 
$37,488 $31,324 $15,324 
v3.23.2
Income Taxes (Tables)
12 Months Ended
Jun. 30, 2023
Income Tax Disclosure [Abstract]  
Provision for (benefit from) income taxes The provision for income taxes is comprised of:
Year Ended June 30, 
202320222021
(in thousands)
U.S. federal taxes:
Current$1,093 $645 $31 
Deferred549 2,260 1,955 
Non-U.S. taxes:
Current4,620 7,749 2,344 
Deferred(404)28,599 (396)
State taxes, net of federal benefit:
Current79 
Total provision for income taxes$5,937 $39,258 $3,935 
Effective income tax rate reconciliation
The reconciliation of the federal statutory income tax rate to our effective income tax rate is as follows (in percentage):

 Year Ended June 30,
 202320222021
United States statutory rate21.0 %21.0 %21.0 %
Stock-based compensation0.2 0.0 0.1 
Foreign taxes, net13.5 (14.3)(14.4)
Outside basis difference on equity method investment(1.0)1.2 — 
Tax credits (13.3)(0.3)(2.4)
Non-deductible expenses1.5 — 2.4 
Tax exempt income(1.5)— — 
Withholding taxes9.0 — — 
Non-deductible executive compensation7.3 0.5 — 
Foreign derived intangible income deduction(7.2)(0.3)— 
Other0.6 0.1 (0.2)
 30.1 %7.9 %6.5 %
Domestic and foreign components of income (loss) The domestic and foreign components of income before taxes are:
 Year Ended June 30, 
 202320222021
(in thousands)
U.S. operations$19,001 $16,684 $9,622 
Non-U.S. operations711 478,386 50,602 
Net income before income taxes$19,712 $495,070 $60,224 
Components of deferred tax assets and liabilities Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of our deferred tax assets and liabilities are as follows:
 June 30, 
 20232022
(in thousands)
Deferred tax assets:
Accrued compensation$2,218 $5,742 
Net operating loss carryforwards18 61 
Depreciation5,360 4,365 
Tax credits15,180 15,079 
Operating lease liabilities4,567 5,807 
Capitalized R&D costs1,116 — 
Accruals and reserves558 643 
Total deferred tax assets29,017 31,697 
Valuation allowance(6,686)(5,755)
Total deferred tax assets, net of valuation allowance22,331 25,942 
Deferred tax liabilities:
Depreciation and amortization(16,899)(18,909)
Right of use assets(4,315)(5,579)
Investments(27,864)(29,619)
Total deferred tax liabilities(49,078)(54,107)
Net deferred tax liabilities
$(26,747)$(28,165)
Schedule of deferred tax assets and liabilities, current and noncurrent
The breakdown between deferred tax assets and liabilities is as follows:
 June 30, 
 20232022
(in thousands)
Long-term deferred tax assets$536 $592 
Long-term deferred tax liabilities(27,283)(28,757)
Net deferred tax liabilities$(26,747)$(28,165)
Unrecognized tax benefits rollforward
A reconciliation of the beginning and ending amount of unrecognized tax benefits from July 1, 2020 to June 30, 2023 is as follows:
 Year Ended June 30, 
 202320222021
(in thousands)
Balance at beginning of year$8,609 $7,645 $7,126 
Additions based on tax positions related to the current year804 1,121 677 
Reductions based on tax positions related to prior years(68)(40)(41)
Reductions due to lapse of applicable statute of limitations(10)(117)(117)
Balance at end of year$9,335 $8,609 $7,645 
v3.23.2
Segment and Geographic information (Tables)
12 Months Ended
Jun. 30, 2023
Segment Reporting [Abstract]  
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas
The revenue by geographical location in the following tables is based on the country or region in which the products were shipped to: 
 Year Ended June 30, 
 202320222021
(in thousands)
Hong Kong$561,855 $630,238 $537,553 
China84,546 120,978 107,325 
South Korea9,168 11,802 5,497 
United States19,744 12,470 5,492 
Other countries16,008 2,064 1,035 
 $691,321 $777,552 $656,902 
 Year Ended June 30, 
 202320222021
 (in thousands)
Power discrete$458,795 $545,135 $482,718 
Power IC218,620 220,882 161,726 
Packaging and testing services3,979 11,535 12,458 
License and development services9,927 — — 
 $691,321 $777,552 $656,902 
Long-lived assets, net consisting of property, plant and equipment and land use rights, net, as well as operating lease right-of-use assets, net by geographical area are as follows:
 June 30,
 20232022
(in thousands)
China$114,822 $105,326 
United States263,083 232,731 
Other countries4,275 4,283 
 $382,180 $342,340 
v3.23.2
The Company and Significant Accounting Policies - Basis of Presentation Narrative (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Property and equipment purchased but not yet paid $ 12,715 $ 62,165 $ 20,204
v3.23.2
The Company and Significant Accounting Policies - Risks and Uncertainties Narrative (Details)
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Cost of Goods and Service, Product and Service Benchmark | Supplier Concentration Risk | HHGrace      
Concentration Risk      
Percent of wafers manufactured 9.60% 10.30% 11.50%
v3.23.2
The Company and Significant Accounting Policies - Joint Venture Narrative (Details)
$ in Thousands, ¥ in Millions
1 Months Ended 12 Months Ended
Jun. 30, 2023
Jan. 26, 2022
USD ($)
Jan. 26, 2022
CNY (¥)
Dec. 31, 2021
Dec. 02, 2021
director
Dec. 01, 2021
Nov. 30, 2021
director
Dec. 31, 2021
USD ($)
Jun. 30, 2023
USD ($)
Jun. 30, 2022
USD ($)
Jun. 30, 2021
USD ($)
Dec. 24, 2021
Related Party Transaction [Line Items]                        
Joint venture cumulative percentage ownership after all transactions                 42.20%      
Proceeds from sale of equity interest in the JV Company | $                 $ 0 $ 26,347 $ 0  
Equity Method Investment, Number of Appointments to Board of Directors | director         3   4          
Number of directors | director         7              
Corporate Joint Venture                        
Related Party Transaction [Line Items]                        
Joint venture cumulative percentage ownership after all transactions 42.20%       48.80%   50.90%          
Proceeds from sale of equity interest in the JV Company | $               $ 16,924        
Third Party Investors | Corporate Joint Venture                        
Related Party Transaction [Line Items]                        
Proceeds from sale of equity interest in the JV Company   $ 80,000 ¥ 509                  
Facility in Liangjiang New Area of Chongqing (the 'Joint Venture') | Third Party Investors | Corporate Joint Venture                        
Related Party Transaction [Line Items]                        
Equity method investment ownership interest   7.82% 7.82%                 1.10%
Facility in Liangjiang New Area of Chongqing (the 'Joint Venture') | Employee Incentive Plan | Corporate Joint Venture | Employee Incentive Plan                        
Related Party Transaction [Line Items]                        
Equity method investment ownership interest                       3.99%
Third Party Investors | Third Party Investors | Corporate Joint Venture                        
Related Party Transaction [Line Items]                        
Equity method investment ownership interest           2.10%           1.10%
Third Party Investors | Employee Incentive Plan | Corporate Joint Venture | Employee Incentive Plan                        
Related Party Transaction [Line Items]                        
Equity method investment ownership interest                       3.99%
Parent Company | Facility in Liangjiang New Area of Chongqing (the 'Joint Venture')                        
Related Party Transaction [Line Items]                        
Joint venture cumulative percentage ownership after all transactions           50.90%            
Chongqing Funds | Facility in Liangjiang New Area of Chongqing (the 'Joint Venture')                        
Related Party Transaction [Line Items]                        
Joint venture cumulative percentage ownership after all transactions       45.80%   49.10%     42.20% 42.20%    
v3.23.2
The Company and Significant Accounting Policies - Restricted Cash Narrative (Details)
$ in Millions
Jun. 30, 2022
USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Restricted cash $ 0.3
v3.23.2
The Company and Significant Accounting Policies - Property and Equipment Useful Lives (Details)
Jun. 30, 2023
Minimum | Software Development  
Property, Plant and Equipment [Line Items]  
Finite-lived intangible asset, useful life 3 years
Maximum | Software Development  
Property, Plant and Equipment [Line Items]  
Finite-lived intangible asset, useful life 5 years
Building and building improvements | Minimum  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment, useful life 20 years
Manufacturing machinery and equipment | Minimum  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment, useful life 7 years
Manufacturing machinery and equipment | Maximum  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment, useful life 10 years
Equipment and tooling | Minimum  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment, useful life 3 years
Equipment and tooling | Maximum  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment, useful life 5 years
Computer equipment and software | Minimum  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment, useful life 3 years
Computer equipment and software | Maximum  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment, useful life 5 years
Office furntiture and equipment | Minimum  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment, useful life 3 years
Office furntiture and equipment | Maximum  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment, useful life 5 years
Leasehold improvements | Minimum  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment, useful life 2 years
Leasehold improvements | Maximum  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment, useful life 15 years
Vehicles  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment, useful life 5 years
v3.23.2
The Company and Significant Accounting Policies - Government Grants (Details) - USD ($)
$ in Millions
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Government grants, reduction recorded to interest expense   $ 0.9 $ 3.0
Government grants, reduction recorded to operating expenses $ 0.1 0.2 3.7
Government grants, reduction recorded to property, plant and equipment $ 0.6 $ 1.4 $ 0.1
v3.23.2
The Company and Significant Accounting Policies - Government Grants Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Government grants, reduction recorded to interest expense   $ 0.9 $ 3.0
Government grants, reduction recorded to operating expenses $ 0.1 0.2 3.7
Government grants, reduction recorded to property, plant and equipment $ 0.6 $ 1.4 $ 0.1
v3.23.2
The Company and Significant Accounting Policies - Revenue Recognition (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Jul. 31, 2023
Mar. 31, 2023
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Feb. 28, 2023
Concentration Risk            
Revenue, Remaining Performance Obligation, Amount           $ 45,000
Revenue     $ 691,321 $ 777,552 $ 656,902  
Upfront Fees   $ 18,000        
Subsequent Event            
Concentration Risk            
Upfront Fees $ 6,800          
License and development services            
Concentration Risk            
Revenue     $ 9,927 $ 0 $ 0  
v3.23.2
The Company and Significant Accounting Policies - Long-lived Assets Narrative (Details) - USD ($)
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Impairment of long-lived assets $ 0 $ 0 $ 0
v3.23.2
The Company and Significant Accounting Policies - Product Warranty Narrative (Details)
12 Months Ended
Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Length of product warranty 1 year
v3.23.2
The Company and Significant Accounting Policies - Advertising Expense Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Advertising expense $ 0.5 $ 0.2 $ 0.4
v3.23.2
Equity Method Investment in Equity Investee - Narrative (Details)
$ in Thousands, ¥ in Millions
1 Months Ended 12 Months Ended
Jun. 30, 2023
Jan. 26, 2022
USD ($)
Jan. 26, 2022
CNY (¥)
Dec. 31, 2021
Dec. 02, 2021
director
Dec. 01, 2021
Nov. 30, 2021
director
Dec. 31, 2021
USD ($)
Jun. 30, 2023
USD ($)
Jun. 30, 2022
USD ($)
Jun. 30, 2021
USD ($)
Dec. 24, 2021
Schedule of Equity Method Investments [Line Items]                        
Joint venture cumulative percentage ownership after all transactions                 42.20%      
Equity Method Investment, Number of Appointments to Board of Directors | director         3   4          
Number of directors | director         7              
Gain on deconsolidation of the JV Company                 $ 0 $ 399,093 $ 0  
Loss on changes of equity interest in the JV Company, net                 0 (3,140) 0  
Proceeds from sale of equity interest in the JV Company                 0 26,347 0  
Equity method investment loss from equity investee                 $ 1,411 $ 2,629 $ 0  
Facility in Liangjiang New Area of Chongqing (the 'Joint Venture') | Chongqing Funds                        
Schedule of Equity Method Investments [Line Items]                        
Joint venture cumulative percentage ownership after all transactions       45.80%   49.10%     42.20% 42.20%    
Corporate Joint Venture                        
Schedule of Equity Method Investments [Line Items]                        
Joint venture cumulative percentage ownership after all transactions 42.20%       48.80%   50.90%          
Gain on deconsolidation of the JV Company               $ 399,093   $ 399,100    
Proceeds from sale of equity interest in the JV Company               $ 16,924        
Third Party Investors | Corporate Joint Venture                        
Schedule of Equity Method Investments [Line Items]                        
Proceeds from sale of equity interest in the JV Company   $ 80,000 ¥ 509                  
Third Party Investors | Corporate Joint Venture | Facility in Liangjiang New Area of Chongqing (the 'Joint Venture')                        
Schedule of Equity Method Investments [Line Items]                        
Equity method investment ownership interest   7.82% 7.82%                 1.10%
Third Party Investors | Corporate Joint Venture | Third Party Investors                        
Schedule of Equity Method Investments [Line Items]                        
Equity method investment ownership interest           2.10%           1.10%
Employee Incentive Plan | Corporate Joint Venture | Facility in Liangjiang New Area of Chongqing (the 'Joint Venture') | Employee Incentive Plan                        
Schedule of Equity Method Investments [Line Items]                        
Equity method investment ownership interest                       3.99%
Employee Incentive Plan | Corporate Joint Venture | Third Party Investors | Employee Incentive Plan                        
Schedule of Equity Method Investments [Line Items]                        
Equity method investment ownership interest                       3.99%
v3.23.2
Equity Method Investment in Equity Investee - Schedule of Gain on Deconsolidation (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Dec. 31, 2021
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Dec. 01, 2021
Schedule of Equity Method Investments [Line Items]          
Cash received for sales of shares in the JV Company   $ 0 $ 26,347 $ 0  
Gain on deconsolidation of the JV Company   $ 0 399,093 $ 0  
Corporate Joint Venture          
Schedule of Equity Method Investments [Line Items]          
Cash received for sales of shares in the JV Company $ 16,924        
Fair value of retained equity method investment 393,124        
Carrying amount of non-controlling interest 143,889        
Cumulative translation adjustment removal 1,793        
Carrying amount of net assets of the JV Company at December 1, 2021         $ (156,637)
Gain on deconsolidation of the JV Company $ 399,093   $ 399,100    
v3.23.2
Equity Method Investment in Equity Investee - Schedule of Net Loss Associated with Sales of JV Company Equity Interest Held (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Schedule of Equity Method Investments [Line Items]      
Loss on changes of equity interest in the JV Company, net $ 0 $ (3,140) $ 0
Loss on diluted equity interest from issuance of shares under the employee equity incentive plan $ (37,488) (31,324) $ (15,324)
Corporate Joint Venture      
Schedule of Equity Method Investments [Line Items]      
Loss on diluted equity interest from issuance of shares under the employee equity incentive plan   (8,116)  
Loss on changes on equity interest of the JV Company, net   (3,140)  
1.1% equity interest sold | Corporate Joint Venture      
Schedule of Equity Method Investments [Line Items]      
Loss on changes of equity interest in the JV Company, net   475  
7.82% equity interest sold | Corporate Joint Venture      
Schedule of Equity Method Investments [Line Items]      
Loss on changes of equity interest in the JV Company, net   $ 4,501  
v3.23.2
Equity Method Investment in Equity Investee - Equity Method Investment, Summarized Financial Information (Details) - USD ($)
$ in Thousands
4 Months Ended 12 Months Ended
Mar. 31, 2022
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Jun. 30, 2021
Schedule of Equity Method Investments [Line Items]          
Current assets   $ 423,936   $ 549,592  
Current liabilities   172,561   267,722  
Gross loss (income)   199,536   268,556 $ 204,543
Operating expenses   177,007   166,518 140,467
Net loss   $ (12,364)   $ (453,163) $ (58,116)
Facility in Liangjiang New Area of Chongqing (the 'Joint Venture')          
Schedule of Equity Method Investments [Line Items]          
Current assets $ 198,323   $ 122,324    
Non-current assets 364,777   333,165    
Current liabilities 251,988   122,340    
Non-current liabilities 76,207   36,525    
Revenue 68,972   178,974    
Gross loss (income) 870   (4,502)    
Operating expenses 2,280   5,939    
Net loss $ 6,197   $ 4,906    
v3.23.2
Related Party Transactions (Details) - USD ($)
$ in Thousands
7 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 02, 2021
Nov. 30, 2021
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Related Party Transaction [Line Items]              
Joint venture cumulative percentage ownership after all transactions         42.20%    
Revenue         $ 691,321 $ 777,552 $ 656,902
Supplies, Assembly And Testing Services              
Related Party Transaction [Line Items]              
Transactions with related party       $ 117,600 127,800    
Corporate Joint Venture              
Related Party Transaction [Line Items]              
Joint venture cumulative percentage ownership after all transactions 42.20% 48.80% 50.90%        
Revenue       36,400      
Corporate Joint Venture | Supplies, Assembly And Testing Services              
Related Party Transaction [Line Items]              
Revenue         35,600    
Related Party              
Related Party Transaction [Line Items]              
Payable related to equity investee, net $ 11,950     $ 28,989 $ 11,950 $ 28,989  
v3.23.2
Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited - Basic and Diluted Income Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Earnings Per Share [Abstract]      
Net income (loss) attributable to AOS $ 12,364 $ 453,163 $ 58,116
Basic:      
Weighted average number of common shares used to compute basic net income (loss) per share 27,552 26,764 25,786
Effect of potentially dilutive securities:      
Stock options, RSUs and ESPP shares 1,976 1,439 1,486
Weighted average number of common shares used to compute diluted net income (loss) per share 29,528 28,203 27,272
Net income (loss) per share attributable to common shareholders:      
Basic (in dollars per share) $ 0.45 $ 16.93 $ 2.25
Diluted (in dollars per share) $ 0.42 $ 16.07 $ 2.13
v3.23.2
Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited - Potential Dilutive Shares (Details) - shares
shares in Thousands
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Incremental common shares attributable to dilutive effect of share-based payment arrangements (USD per share) 1,976 1,439 1,486
Potential dilutive securities (in shares) 619 298 264
Employee stock options and RSUs      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potential dilutive securities (in shares) 310 277 193
Employee Stock      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potential dilutive securities (in shares) 309 21 71
v3.23.2
Concentration of Credit Risk and Significant Customers - Schedule of Concentration Risk (Details)
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Minimum      
Concentration Risk      
Terms of credit sales, (in days) 30 days    
Maximum      
Concentration Risk      
Terms of credit sales, (in days) 60 days    
Customer A | Revenue Benchmark | Customer Concentration Risk      
Concentration Risk      
Concentration risk, percentage 21.60% 24.60% 28.70%
Customer A | Accounts Receivable | Customer Concentration Risk      
Concentration Risk      
Concentration risk, percentage 15.30% 24.60%  
Customer B | Revenue Benchmark | Customer Concentration Risk      
Concentration Risk      
Concentration risk, percentage 35.60% 39.70% 35.40%
Customer B | Accounts Receivable | Customer Concentration Risk      
Concentration Risk      
Concentration risk, percentage 17.60% 36.40%  
Customer C | Accounts Receivable | Customer Concentration Risk      
Concentration Risk      
Concentration risk, percentage 13.30%    
Customer D | Revenue Benchmark | Customer Concentration Risk      
Concentration Risk      
Concentration risk, percentage 14.00%    
Customer D | Accounts Receivable | Customer Concentration Risk      
Concentration Risk      
Concentration risk, percentage 30.90% 12.00%  
v3.23.2
Balance Sheet Components - Accounts receivable (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Jun. 30, 2022
Balance Sheet Related Disclosures [Abstract]    
Accounts receivable $ 62,426 $ 84,442
Less: Allowance for price adjustments (39,976) (18,731)
Less: Allowance for doubtful accounts (30) (30)
Accounts receivable, net $ 22,420 $ 65,681
v3.23.2
Balance Sheet Components - Inventories (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Jun. 30, 2022
Balance Sheet Related Disclosures [Abstract]    
Raw materials $ 86,620 $ 67,960
Work in-process 69,426 80,720
Finished goods 27,201 9,360
Inventories $ 183,247 $ 158,040
v3.23.2
Balance Sheet Components - Other Current Assets (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Jun. 30, 2022
Balance Sheet Related Disclosures [Abstract]    
VAT receivable $ 275 $ 737
Other prepaid expenses 3,863 3,954
Prepaid insurance 4,162 2,590
Prepaid maintenance 1,697 826
Prepayments to supplier 10,689 257
Prepaid income tax 707 2,086
Interest receivable 135 25
Other receivables 1,138 745
Total other current assets $ 22,666 $ 11,220
v3.23.2
Balance Sheet Components - Property, plant, and equipment (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Property, Plant and Equipment [Line Items]      
Property, plant, and equipment excluding equipment and construction In progress, gross $ 554,613 $ 422,026  
Less accumulated depreciation (272,503) (233,340)  
Property, plant and equipment excluding equipment and construction in progress, net 282,110 188,686  
Equipment and construction in progress 75,721 129,980  
Property, plant and equipment, net 357,831 318,666  
Depreciation expense 40,400 39,900  
Capitalized software development costs 500 300 $ 300
Capitalized computer software, amortization 400 400 $ 500
Unamortized capitalized software development costs 900 800  
Finance lease liabilities 867 802  
Accumulated depreciation 657 136  
Land      
Property, Plant and Equipment [Line Items]      
Property, plant, and equipment excluding equipment and construction In progress, gross 4,877 4,877  
Building and building improvements      
Property, Plant and Equipment [Line Items]      
Property, plant, and equipment excluding equipment and construction In progress, gross 26,478 16,691  
Manufacturing machinery and equipment      
Property, Plant and Equipment [Line Items]      
Property, plant, and equipment excluding equipment and construction In progress, gross 398,757 287,574  
Equipment and tooling      
Property, Plant and Equipment [Line Items]      
Property, plant, and equipment excluding equipment and construction In progress, gross 32,737 28,052  
Computer equipment and software      
Property, Plant and Equipment [Line Items]      
Property, plant, and equipment excluding equipment and construction In progress, gross 49,890 46,758  
Office furniture and equipment      
Property, Plant and Equipment [Line Items]      
Property, plant, and equipment excluding equipment and construction In progress, gross 3,087 2,820  
Leasehold improvements      
Property, Plant and Equipment [Line Items]      
Property, plant, and equipment excluding equipment and construction In progress, gross $ 38,787 $ 35,254  
v3.23.2
Balance Sheet Components - Goodwill (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Jun. 30, 2022
Balance Sheet Related Disclosures [Abstract]    
Goodwill $ 269 $ 269
v3.23.2
Balance Sheet Components - Other long term assets (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Jun. 30, 2022
Balance Sheet Related Disclosures [Abstract]    
Prepayments for property and equipment $ 1,717 $ 6,890
Investment in privately held companies 100 100
Customs deposit 931 1,708
Deposit with supplier 12,290 6,396
Other long-term deposits 37 18
Office leases deposits 1,274 1,012
Other 3,354 1,553
Other long-term assets $ 19,703 $ 17,677
v3.23.2
Balance Sheet Components - Future amortization expense of intangible assets (Details)
$ in Thousands
Jun. 30, 2023
USD ($)
Balance Sheet Related Disclosures [Abstract]  
2024 $ 3,249
2025 3,247
Intangible assets, net $ 6,496
v3.23.2
Balance Sheet Components - Intangible assets (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Acquired Finite-Lived Intangible Assets [Line Items]      
Intangible assets, gross $ 19,455 $ 19,455  
Less accumulated amortization (12,959) (9,674)  
Intangible assets, net (excluding goodwill) 6,496 9,781  
Goodwill 269 269  
Intangible assets, net 6,765 10,050  
Amortization expense 3,300 3,400 $ 3,400
Patents and exclusive technology rights      
Acquired Finite-Lived Intangible Assets [Line Items]      
Intangible assets, gross $ 18,037 18,037  
Finite-lived intangible asset, useful life 5 years    
Trade name      
Acquired Finite-Lived Intangible Assets [Line Items]      
Intangible assets, gross $ 268 268  
Finite-lived intangible asset, useful life 10 years    
Customer relationships      
Acquired Finite-Lived Intangible Assets [Line Items]      
Intangible assets, gross $ 1,150 $ 1,150  
v3.23.2
Balance Sheet Components - Accrued liabilities (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Concentration Risk        
Accrued compensation and benefits $ 15,627 $ 34,681    
Warranty accrual 1,674 2,650 $ 2,795 $ 709
Stock rotation accrual 5,588 4,798 $ 3,917 $ 3,358
Accrued professional fees 2,458 2,659    
Accrued inventory 1,597 2,491    
Accrued facilities related expenses 2,327 2,421    
Accrued property, plant and equipment 6,402 20,485    
Other accrued expenses 4,401 5,159    
Customer deposit 38,082 40,578    
ESPP payable 1,377 971    
Accrued liabilities 79,533 116,893    
Customer A        
Concentration Risk        
Customer deposit 13,500 12,500    
Customer B        
Concentration Risk        
Customer deposit 9,200 16,200    
Other Customer        
Concentration Risk        
Customer deposit $ 15,400 $ 11,900    
v3.23.2
Balance Sheet Components - Product Warranty Accrual (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]      
Beginning balance $ 2,650 $ 2,795 $ 709
Addition 3,666 1,127 2,443
Utilization (4,642) (1,272) (357)
Ending balance $ 1,674 $ 2,650 $ 2,795
v3.23.2
Balance Sheet Components - Stock Rotation Accrual (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Stock Rotation Accrual Increae (Decrease) [Roll Forward]      
Beginning balance $ 4,798 $ 3,917 $ 3,358
Addition 13,950 5,817 4,742
Utilization (13,160) (4,936) (4,183)
Ending balance $ 5,588 $ 4,798 $ 3,917
v3.23.2
Balance Sheet Components - Impairment of long-lived assets, intangible assets, and goodwill (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Jun. 30, 2022
Balance Sheet Related Disclosures [Abstract]    
Goodwill $ 269 $ 269
v3.23.2
Balance Sheet Components - Other long-term liabilities (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Jun. 30, 2022
Concentration Risk    
Customer deposits $ 46,393 $ 70,301
Computer software liabilities 4,644 8,302
Other long-term liabilities 51,037 78,603
Customer A    
Concentration Risk    
Customer deposits 21,000 34,500
Customer B    
Concentration Risk    
Customer deposits 11,700 21,900
Other Customers    
Concentration Risk    
Customer deposits $ 13,700 $ 13,900
v3.23.2
Debt - Short-term borrowing (Details)
1 Months Ended 3 Months Ended
Oct. 31, 2019
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2021
CNY (¥)
Jun. 30, 2023
USD ($)
Jan. 31, 2023
USD ($)
Jan. 31, 2023
CNY (¥)
Sep. 20, 2022
USD ($)
Sep. 20, 2022
CNY (¥)
Jun. 30, 2022
USD ($)
Sep. 30, 2021
CNY (¥)
Oct. 31, 2019
CNY (¥)
Nov. 16, 2018
CNY (¥)
Short-term Debt [Line Items]                        
Short-term debt       $ 11,434,000         $ 25,563,000      
Bank Of Communications Limited                        
Short-term Debt [Line Items]                        
Short-term debt       0                
Maximum borrowing capacity $ 8,500,000                 ¥ 140,000,000 ¥ 60,000,000  
Bank Of Communications Limited | Credit Facility, 3 Point 85 Percent, Due November 18, 2022                        
Short-term Debt [Line Items]                        
Proceeds from short-term debt   $ 1,600,000 ¥ 11,000,000                  
Stated interest rate   3.85% 3.85%                  
Bank Of Communications Limited | Line Of Credit Maturing December 1 2023 | Line of Credit                        
Short-term Debt [Line Items]                        
Maximum borrowing capacity         $ 20,600,000 ¥ 140,000,000            
Long-Term Line of Credit       0                
Industrial And Commercial Bank of China | Foreign Line of Credit                        
Short-term Debt [Line Items]                        
Short-term debt       $ 0     $ 10,300,000 ¥ 72,000,000       ¥ 72,000,000
Interest rate   370.00% 370.00%                  
Proceeds from short-term debt   $ 800,000 ¥ 5,000,000                  
Industrial And Commercial Bank of China | Foreign Line of Credit | Line of Credit Facility, Trade Borrowings                        
Short-term Debt [Line Items]                        
Maximum borrowing capacity | ¥                       27,000,000
Industrial And Commercial Bank of China | Foreign Line of Credit | Line of Credit Facility, Working Capital Borrowings                        
Short-term Debt [Line Items]                        
Maximum borrowing capacity | ¥                       ¥ 45,000,000
Base Rate | China | Bank Of Communications Limited                        
Short-term Debt [Line Items]                        
Basis spread on variable rate 4.99%                      
Basis spread multiple 1.05                   1.05  
v3.23.2
Debt - Accounts Receivable Factoring Agreement (Details) - Secured Debt - Accounts Receivable Factoring Agreement August Ninth Two Thousand Nineteen - USD ($)
Aug. 09, 2019
Jun. 30, 2023
Aug. 11, 2021
Debt Instrument [Line Items]      
Accounts Receivable Factoring Agreement, maximum borrowing capacity, percent of net accounts receivable 70.00%    
Accounts Receivable Factoring Agreement, maximum borrowing capacity $ 30,000,000    
Basis spread on variable rate 1.75%    
Accounts Receivable Factoring Agreement, borrowed amount outstanding   $ 0  
Accounts Receivable Factoring Agreement, remaining borrowing capacity   $ 8,000,000  
Accounts Receivable Factoring Agreement, reduction of maximum borrowing capacity     $ 8,000,000
v3.23.2
Debt - Debt Financing (Details)
€ in Millions
1 Months Ended
Oct. 31, 2022
Sep. 30, 2022
USD ($)
Sep. 30, 2021
USD ($)
Jun. 30, 2023
USD ($)
Jun. 30, 2022
EUR (€)
Sep. 30, 2021
EUR (€)
Apr. 30, 2021
EUR (€)
Sale Leaseback Transaction [Line Items]              
Sale Leaseback Transaction, Lease Completion Buyout Option, Amount     $ 1        
Jireh Semiconductor Incorporated | Sales-Lease Back Transaction with Jireh Semiconductor Incorporated              
Sale Leaseback Transaction [Line Items]              
Historical cost | €           € 12.0  
Down payment amount received | €             € 6.0
Down payment percent   50.00%         50.00%
Delivery payment received | €         € 4.8    
Delivery payment percent         40.00%    
Purchase price financing amount, percent   10.00%          
Lease term (in years)     5 years        
Implied interest rate, percent 7.51%   4.75%        
Payments for Purchase of Other Assets   $ 200,000          
Sales Leaseback Transaction, Debt Outstanding, Amount       $ 11,900,000      
Jireh Semiconductor Incorporated | Sales-Lease Back Transaction with Jireh Semiconductor Incorporated | Manufacturing machinery and equipment              
Sale Leaseback Transaction [Line Items]              
Debt instrument, collateral amount       $ 15,200,000      
v3.23.2
Debt - Credit Facilities and Long-term Debt Narrative (Details) - USD ($)
$ in Thousands
Feb. 16, 2022
Aug. 18, 2021
May 01, 2018
Aug. 15, 2017
Jun. 30, 2023
Jun. 30, 2022
Jul. 31, 2018
Jan. 12, 2018
Line of Credit Facility [Line Items]                
Long-term debt         $ 38,360      
Restricted cash           $ 300    
Secured Debt                
Line of Credit Facility [Line Items]                
Maximum borrowing capacity     $ 17,800          
Debt term     5 years          
Stated interest rate     5.04%          
Secured Debt | Jireh                
Line of Credit Facility [Line Items]                
Maximum borrowing capacity   $ 45,000            
Amount outstanding         38,300      
Proceeds from lines of credit $ 45,000              
Debt term   5 years 6 months            
Variable Interest Rate Term Loan Maturing August 2022 | Secured Debt | Term Loan                
Line of Credit Facility [Line Items]                
Maximum borrowing capacity       $ 30,000        
Amount outstanding         $ 0   $ 16,700 $ 13,200
Debt term       5 years        
Variable Interest Rate Term Loan Maturing August 2022 | Minimum | LIBOR | Secured Debt | Term Loan                
Line of Credit Facility [Line Items]                
Basis spread on variable rate       1.75%        
Variable Interest Rate Term Loan Maturing August 2022 | Maximum | LIBOR | Secured Debt | Term Loan                
Line of Credit Facility [Line Items]                
Basis spread on variable rate       2.25%        
v3.23.2
Debt - Maturities of Short-tem and Long-term Debt (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Jun. 30, 2022
Debt Disclosure [Abstract]    
2024 $ 11,472  
2025 11,664  
2026 11,871  
2027 14,344  
2028 536  
Total principal of debt 49,887  
Less: debt issuance costs (93)  
Total debt, less debt issuance costs 49,794  
Short-term Debt    
Principal amount 11,472  
Less: debt issuance costs (38)  
Total debt, less debt issuance costs 11,434 $ 25,563
Long-term Debt    
Principal amount 38,415  
Less: debt issuance costs (55)  
Total principal of debt, less debt issuance costs 38,360  
Total    
Principal amount 49,887  
Less: debt issuance costs (93)  
Total debt, less debt issuance costs $ 49,794  
v3.23.2
Leases - Narrative (Details)
$ in Millions
Jun. 30, 2023
USD ($)
Leases [Abstract]  
Finance Lease, Right-Of-Use Asset, Gross $ 5.1
v3.23.2
Leases - Schedule of Lease Cost (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Operating leases:    
Fixed rent expense $ 5,779 $ 6,262
Variable rent expense 1,014 946
Finance lease:    
Amortization of equipment 522 908
Interest 306 976
Short-term leases:    
Short-term lease expenses 400 205
Total lease expenses $ 8,021 $ 9,297
v3.23.2
Leases - Schedule of Lease Supplemental Balance Sheet Information (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Jun. 30, 2022
Operating Lease Right Of Use Asset [Abstract]    
ROU assets associated with operating leases $ 24,349 $ 23,674
Finance Lease:    
Property, plant and equipment, gross 5,133 4,831
Accumulated depreciation (657) (136)
Property, plant and equipment, net $ 4,476 $ 4,695
Weighted average remaining lease term (in years)    
Operating leases 6 years 6 months 25 days 7 years 5 months 1 day
Finance lease 4 years 3 months 5 years
Weighted average discount rate    
Operating leases 4.67% 4.27%
Finance lease 7.51% 4.76%
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Property, plant and equipment, net Property, plant and equipment, net
v3.23.2
Leases - Schedule of Lease Supplemental Cash Flow Information (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash paid from amounts included in the measurement of lease liabilities:    
Operating cash flows from operating leases $ 5,945 $ 6,480
Operating cash flows from finance lease 306 976
Financing cash flows from finance lease 810 4,176
Non-cash investing and financing information:    
Operating lease right-of-use assets obtained in exchange for lease obligations $ 5,579 $ 5,852
v3.23.2
Leases - Schedule of Lease Maturities - Topic 842 (Details)
$ in Thousands
Jun. 30, 2023
USD ($)
Lessee, Operating Lease, Liability, Payment, Due [Abstract]  
2021 $ 5,452
2022 4,623
2023 3,807
2024 3,647
2025 3,317
Thereafter 8,303
Total minimum lease payments 29,149
Less amount representing interest (4,222)
Total lease liabilities 24,927
Finance Lease, Liability, Payment, Due [Abstract]  
2021 1,144
2022 1,144
2023 1,144
2024 1,145
2025 191
Thereafter 0
Total minimum lease payments 4,768
Less amount representing interest (685)
Total lease liabilities $ 4,083
v3.23.2
Shareholders' Equity (Details)
$ / shares in Units, $ in Thousands
12 Months Ended 152 Months Ended
Jun. 30, 2023
USD ($)
votes
$ / shares
shares
Jun. 30, 2022
$ / shares
shares
Jun. 30, 2021
shares
Jun. 30, 2023
USD ($)
votes
$ / shares
shares
Common Shares        
Common shares, authorized (in shares) | shares 100,000,000 100,000,000   100,000,000
Common shares, par value (in dollars per share) $ 0.002 $ 0.002   $ 0.002
Number of votes per each common share | votes 1     1
Common stock, dividends declared per share $ 0      
Treasury Shares        
Share repurchase program, authorized amount | $ $ 30,000     $ 30,000
Share repurchase program, remaining authorized amount | $ $ 0     $ 0
Treasury stock acquired, shares repurchased (in shares) | shares 548,132 0 0 7,332,780
Repurchase of common shares under share repurchase program | $ $ 13,432      
Treasury stock acquired less handling fees | $       $ 81,100
Treasury stock acquired, average price per share (in dollars per share) $ 24.51     $ 11.01
Treasury stock retired (in shares) | shares       0
Treasury Stock Reissued        
Treasury Shares        
Treasury stock acquired, average price per share (in dollars per share)       $ 9.97
Treasury stock reissued (in shares) | shares       175,599
Treasury stock reissued average price per share       $ 4.76
v3.23.2
Share-based Compensation - Narrative (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Aug. 31, 2020
Aug. 30, 2020
Nov. 30, 2022
Dec. 31, 2021
Nov. 30, 2021
Sep. 30, 2018
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Nov. 30, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Allocated share-based compensation expense             $ 37,488,000 $ 31,324,000 $ 15,324,000    
Grants in period (in shares)             0 0 0    
Weighted Average Remaining Recognition Period (Years)             2 years 2 months 12 days        
Deferred compensation share-based arrangements, liability, current               $ 0 $ 100,000    
Share-based payment arrangement, expense, non-cash               300,000 $ 3,100,000 $ 600,000  
Market-based Restricted Stock Units (MSU)                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Risk-free interest rate       1.00%              
Expected term (in years)       3 years 1 month 6 days              
Volatility rate       62.80%              
Dividend yield       0.00%              
Allocated share-based compensation expense             $ 1,900,000 $ 4,500,000      
Weighted Average Remaining Recognition Period (Years)             2 years 11 months 15 days 3 years 9 months 29 days 3 years 10 months 2 days 3 years 10 months 17 days  
Granted (in shares)       1,000,000   1,300,000   1,022,000      
Market-based Restricted Stock Units (MSU) | Minimum                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Award requisite service period       4 years 1 month 6 days              
Market-based Restricted Stock Units (MSU) | Maximum                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Award requisite service period       7 years 1 month 6 days              
Market-based Restricted Stock Units (MSU), Pre-Modification                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Risk-free interest rate   0.13%                  
Expected term (in years)   1 year 3 months 18 days                  
Volatility rate   66.70%                  
Dividend yield   0.00%                  
Market-based Restricted Stock Units (MSU), Post-Modification                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Risk-free interest rate 0.14%                    
Expected term (in years) 2 years 3 months 18 days                    
Volatility rate 59.10%                    
Dividend yield 0.00%                    
Allocated share-based compensation expense             $ 3,900,000 $ 1,600,000 $ 1,200,000    
Employee Stock                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Shares authorized under plan (in shares)         2,500,000           1,430,000
Grant price, percent of fair value of common stock at date of grant             85.00%        
Expected term (in years)             1 year 3 months 18 days 1 year 3 months 18 days 1 year 3 months 18 days    
Dividend yield             0.00% 0.00% 0.00%    
Payroll deduction accumulation period (in months)             6 months        
Performance Based Restricted Stock Units (PRSUs)                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Granted, value               $ 4,000,000      
Allocated share-based compensation expense             $ 5,200,000 $ 4,600,000 $ 2,300,000    
Weighted Average Remaining Recognition Period (Years)             1 year 9 months 10 days 1 year 10 months 6 days 1 year 8 months 26 days 1 year 7 months 6 days  
Granted (in shares)             264,214 194,000 165,500    
2018 Omnibus Incentive Plan | Stock Options | Minimum                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Grant price, percent of fair value of common stock at date of grant             100.00%        
2018 Omnibus Incentive Plan | Nonstatutory Stock Options | Minimum                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Grant price, percent of fair value of common stock at date of grant             85.00%        
2018 Omnibus Incentive Plan | Employee stock options and RSUs                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Number of shares available for grant (in shares)             611,994        
Stock options exercisable term (in years)             10 years        
2018 Omnibus Incentive Plan | Employee stock options and RSUs | Minimum                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Award vesting period (in years)             4 years        
2018 Omnibus Incentive Plan | Employee stock options and RSUs | Maximum                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Shares authorized under plan (in shares)     3,805,000               2,065,000
Award vesting period (in years)             5 years        
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized     740,000   1,000,000            
2018 Omnibus Incentive Plan | Restricted Stock Units (RSUs) | Minimum                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Grant price, percent of fair value of common stock at date of grant             100.00%        
2018 Omnibus Incentive Plan | External Board Members | Restricted Stock Units (RSUs)                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Granted, value             $ 135,000        
Average fair market value per share period             90 days        
2018 Omnibus Incentive Plan | External Board Members | Restricted Stock Units (RSUs) | Maximum                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Granted (in shares)             10,000        
v3.23.2
Share-based Compensation - Nonvested Share Activity Rollforward (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Dec. 31, 2021
Sep. 30, 2018
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]            
Allocated share-based compensation expense     $ 37,488,000 $ 31,324,000 $ 15,324,000  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]            
Weighted Average Remaining Recognition Period (Years)     2 years 2 months 12 days      
Market-based Restricted Stock Units (MSU)            
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]            
Allocated share-based compensation expense     $ 1,900,000 $ 4,500,000    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares            
Nonvested (in shares)     2,206,000 1,240,000 1,290,000  
Granted (in shares) 1,000,000 1,300,000   1,022,000    
Vested (in shares)     (90,000)      
Forfeited (in shares)     (8,000) (56,000) (50,000)  
Nonvested (in shares)     2,108,000 2,206,000 1,240,000 1,290,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]            
Nonvested (in dollars per share)     $ 25.10 $ 5.17 $ 5.17  
Granted (in dollars per share)       48.44    
Vested (in dollars per share)     5.17      
Forfeited (in dollars per share)     48.44 9.81 5.17  
Nonvested (in dollars per share)     $ 25.86 $ 25.10 $ 5.17 $ 5.17
Weighted Average Remaining Recognition Period (Years)     2 years 11 months 15 days 3 years 9 months 29 days 3 years 10 months 2 days 3 years 10 months 17 days
Aggregate intrinsic value, nonvested     $ 69,142,400 $ 73,548,040 $ 37,683,600 $ 14,035,200
Expected term (in years) 3 years 1 month 6 days          
Dividend yield 0.00%          
Restricted Stock [Member]            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares            
Nonvested (in shares)     1,169,609 1,053,524 932,138  
Granted (in shares)     714,080 597,381 722,873  
Vested (in shares)     (451,549) (410,670) (567,087)  
Forfeited (in shares)     (47,075) (70,626) (34,400)  
Nonvested (in shares)     1,385,065 1,169,609 1,053,524 932,138
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]            
Nonvested (in dollars per share)     $ 34.03 $ 21.60 $ 11.36  
Granted (in dollars per share)     27.70 45.83 29.85  
Vested (in dollars per share)     28.84 20.54 15.70  
Forfeited (in dollars per share)     33.40 26.79 14.88  
Nonvested (in dollars per share)     $ 32.48 $ 34.03 $ 21.60 $ 11.36
Weighted Average Remaining Recognition Period (Years)     1 year 8 months 23 days 1 year 8 months 23 days 1 year 8 months 23 days 1 year 7 months 28 days
Aggregate intrinsic value, nonvested     $ 45,430,132 $ 38,994,764 $ 32,016,594 $ 10,141,661
Performance Based Restricted Stock Units (PRSUs)            
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]            
Allocated share-based compensation expense     $ 5,200,000 $ 4,600,000 $ 2,300,000  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares            
Nonvested (in shares)     389,375 353,824 342,775  
Granted (in shares)     264,214 194,000 165,500  
Vested (in shares)     (116,132) (151,199) (148,211)  
Forfeited (in shares)     (10,743) (7,250) (6,240)  
Nonvested (in shares)     526,714 389,375 353,824 342,775
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]            
Nonvested (in dollars per share)     $ 36.56 $ 22.69 $ 12.38  
Granted (in dollars per share)     25.70 48.65 36.27  
Vested (in dollars per share)     30.54 19.44 14.24  
Forfeited (in dollars per share)     48.65 40.33 17.23  
Nonvested (in dollars per share)     $ 32.19 $ 36.56 $ 22.69 $ 12.38
Weighted Average Remaining Recognition Period (Years)     1 year 9 months 10 days 1 year 10 months 6 days 1 year 8 months 26 days 1 year 7 months 6 days
Aggregate intrinsic value, nonvested     $ 17,276,219 $ 12,981,763 $ 10,752,711 $ 3,729,392
v3.23.2
Share-based Compensation - Summary of Stock Option Activities (Details) - USD ($)
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]        
Outstanding (in shares) 389,875 487,875 643,978  
Granted (in shares) 0 0 0  
Exercised (in shares) (65,500) (98,000) (156,103)  
Canceled or forfeited (in shares) (5,000) 0 0  
Outstanding (in shares) 319,375 389,875 487,875 643,978
Options vested and expected to vest (in shares) 319,375      
Exercisable (in shares) 319,375      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]        
Outstanding (in dollars per share) $ 7.70 $ 7.99 $ 8.79  
Granted (in dollars per share) 0 0 0  
Exercised (in dollars per share) 8.42 9.15 11.31  
Canceled or forfeited (in dollars per share) 9.19 0 0  
Outstanding (in dollars per share) 7.53 $ 7.70 $ 7.99 $ 8.79
Options vested and expected to vest (in dollars per share) 7.53      
Exercisable (in dollars per share) $ 7.53      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]        
Outstanding, Weighted Average Remaining Contractual Term (in years) 8 months 19 days 1 year 6 months 10 days 2 years 3 months 25 days 2 years 10 months 20 days
Options, vested and expected to vest, Weighted Average Remaining Contractual Term (in years) 8 months 19 days      
Exercisable, Weighted Average Remaining Contractual Term (in years) 8 months 19 days      
Aggregate Intrinsic Value, Exercised $ 1,442,646 $ 3,936,675 $ 1,272,291  
Aggregate Intrinsic Value, Outstanding 8,071,631      
Options, vested and expected to vest, outstanding, aggregate intrinsic value 8,071,631      
Exercisable, Intrinsic Value $ 8,071,631      
v3.23.2
Share-based Compensation - Fair Value Weighted Average Assumptions (Details) - Employee Stock
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Volatility rate, minimum 64.00% 66.40% 63.10%
Volatility rate, maximum 70.50% 69.90% 68.50%
Risk-free interest rate, minimum 4.50% 0.30% 0.10%
Risk-free interest rate, maximum 4.60% 2.10% 0.20%
Expected term (in years) 1 year 3 months 18 days 1 year 3 months 18 days 1 year 3 months 18 days
Dividend yield 0.00% 0.00% 0.00%
v3.23.2
Share-based Compensation - Employee Share Purchase Plan (Details) - Employee Stock - USD ($)
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Nov. 30, 2021
Nov. 30, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Duration of offering periods for ESPP (in months) 24 months        
Percent of compensation allowed for purchase of options 15.00%        
Payroll deduction accumulation period (in months) 6 months        
Grant price, percent of fair value of common stock at date of grant 85.00%        
Maximum number of shares authorized for purchase per purchase date (in shares) 300,000        
Shares authorized under plan (in shares)       2,500,000 1,430,000
Weighted-average grant date fair value $ 11.46 $ 16.48 $ 11.11    
Maximum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Maximum number of common shares that may be purchased on any purchase date by a participant (in shares) 875        
Maximum number of common shares that may be purchased per a 24-month offering period by a participant (in shares) 3,500        
Maximum value of common stock that may be purchased in any one calendar year $ 25,000        
v3.23.2
Share-based Compensation - Share-based Compensation Expenses (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Allocated share-based compensation expense $ 37,488 $ 31,324 $ 15,324  
Unrecognized compensation expense $ 56,100      
Recognition period of share-based compensation expense (in years) 2 years 2 months 12 days      
Cost of goods sold        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Allocated share-based compensation expense $ 5,851 5,125 1,756  
Research and development        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Allocated share-based compensation expense 9,437 7,049 5,352  
Selling, general and administrative        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Allocated share-based compensation expense 22,200 19,150 8,216  
Performance Based Restricted Stock Units (PRSUs)        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Allocated share-based compensation expense $ 5,200 $ 4,600 $ 2,300  
Granted (in shares) 264,214 194,000 165,500  
Recognition period of share-based compensation expense (in years) 1 year 9 months 10 days 1 year 10 months 6 days 1 year 8 months 26 days 1 year 7 months 6 days
v3.23.2
Employee Benefit Plans (Details) - USD ($)
$ in Millions
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Retirement Benefit Plan Disclosure [Line Items]    
Employer matching contribution, percent of match 50.00%  
Employer matching contribution, percent of employees' gross pay 4.00%  
Company contributions to retirement plan $ 1.0 $ 0.3
Defined Contribution Plan, Employer Matching Contribution, Eligible Compensation Maximum Match, Percent 2.00%  
United States    
Retirement Benefit Plan Disclosure [Line Items]    
Mandatory employer contributions according to labor and social security laws and regulations, percent 7.70%  
United States | Retirement Plan, 401-K    
Retirement Benefit Plan Disclosure [Line Items]    
Employee maximum salary deferral contribution, percent 100.00%  
Taiwan    
Retirement Benefit Plan Disclosure [Line Items]    
Mandatory employer contributions according to labor and social security laws and regulations, percent 6.00%  
China | Minimum    
Retirement Benefit Plan Disclosure [Line Items]    
Mandatory employer contributions according to labor and social security laws and regulations, percent 15.00%  
China | Maximum    
Retirement Benefit Plan Disclosure [Line Items]    
Mandatory employer contributions according to labor and social security laws and regulations, percent 16.00%  
INDIA    
Retirement Benefit Plan Disclosure [Line Items]    
Mandatory employer contributions according to labor and social security laws and regulations, percent 12.00%  
v3.23.2
Income Taxes - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2020
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Tax Credit Carryforward [Line Items]          
Valuation allowance   $ 6,686 $ 5,755    
Valuation allowance increase   900 35,700    
Tax credit carry forward   8,000      
Undistributed earnings of foreign subsidiaries   374,000      
Unrecognized tax benefits   9,335 8,609 $ 7,645 $ 7,126
Unrecognized tax benefit, amount netted against deferred tax assets   6,800      
Unrecognized tax benefits that would reduce effective income tax rate   6,300      
Decrease in unrecognized tax benefits is reasonably possible   0      
Income tax interest and penalties accrued   300 200    
Income tax interest and penalties expense   100 32    
Income tax benefit $ (1,100) 5,937 39,258 3,935  
Long-term Income Tax Payable          
Tax Credit Carryforward [Line Items]          
Unrecognized tax benefits   2,500      
State          
Tax Credit Carryforward [Line Items]          
Tax credit carryforward, not subject to expiration   9,000      
Corporate Joint Venture          
Tax Credit Carryforward [Line Items]          
Deferred tax liability   27,900      
State research and development credit carryforward          
Tax Credit Carryforward [Line Items]          
Valuation allowance   $ 6,700 5,800    
Net operating loss, fixed asset and intangible asset | Corporate Joint Venture          
Tax Credit Carryforward [Line Items]          
Valuation allowance     $ 0 $ 35,700  
v3.23.2
Income Taxes - Income Tax Schedules (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2020
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
U.S. federal taxes:        
Current   $ 1,093 $ 645 $ 31
Deferred   549 2,260 1,955
Non-U.S. taxes:        
Current   4,620 7,749 2,344
Deferred   (404) 28,599 (396)
State taxes, net of federal benefit:        
Current   79 5 1
Total provision for income taxes $ (1,100) $ 5,937 $ 39,258 $ 3,935
Effective income tax rate reconciliation        
United States statutory rate   21.00% 21.00% 21.00%
Stock-based compensation   0.20% 0.00% 0.10%
Foreign taxes, net   13.50% (14.30%) (14.40%)
Outside basis difference on equity method investment   (1.00%) 1.20% 0.00%
Tax credits   (13.30%) (0.30%) (2.40%)
Non-deductible expenses   1.50% 0.00% 2.40%
Tax exempt income   (1.50%) 0.00% 0.00%
Withholding taxes   0.090 0 0
Non-deductible executive compensation   0.073 0.005 0
Foreign derived intangible income deduction   (7.20%) (0.30%) 0.00%
Other   0.60% 0.10% (0.20%)
Effective income tax rate   30.10% 7.90% 6.50%
Domestic and foreign components of income (loss) before taxes        
U.S. operations   $ 19,001 $ 16,684 $ 9,622
Non-U.S. operations   711 478,386 50,602
Net income before income taxes   19,712 495,070 60,224
Deferred tax assets:        
Accrued compensation   2,218 5,742  
Net operating loss carryforwards   18 61  
Depreciation   5,360 4,365  
Tax credits   15,180 15,079  
Operating lease liabilities   4,567 5,807  
Capitalized R&D costs   1,116 0  
Accruals and reserves   558 643  
Total deferred tax assets   29,017 31,697  
Valuation allowance   (6,686) (5,755)  
Total deferred tax assets, net of valuation allowance   22,331 25,942  
Deferred tax liabilities:        
Depreciation and amortization   (16,899) (18,909)  
Right of use assets   (4,315) (5,579)  
Investments   (27,864) (29,619)  
Total deferred tax liabilities   (49,078) (54,107)  
Current and non-current deferred tax assets and liabilities        
Long-term deferred tax assets   536 592  
Net deferred tax liabilities   (26,747) (28,165)  
Unrecognized tax benefits rollforward        
Balance at beginning of year   8,609 7,645 7,126
Additions based on tax positions related to the current year   804 1,121 677
Reductions based on tax positions related to prior years   (68) (40) (41)
Reductions due to lapse of applicable statute of limitations   (10) (117) (117)
Balance at end of year   9,335 8,609 $ 7,645
Tax Credit Carryforward [Line Items]        
Deferred Tax Liabilities, Gross   49,078 54,107  
Long Term Liabilities        
Deferred tax liabilities:        
Total deferred tax liabilities   (27,283) (28,757)  
Tax Credit Carryforward [Line Items]        
Deferred Tax Liabilities, Gross   $ 27,283 $ 28,757  
v3.23.2
Segment and Geographic information Segment Narrative (Details)
$ in Thousands
1 Months Ended 12 Months Ended
Feb. 28, 2023
USD ($)
Jun. 30, 2023
USD ($)
Segment
Jun. 30, 2022
USD ($)
Jun. 30, 2021
USD ($)
Segment Reporting Information        
Number of operating segments | Segment   1    
Revenue   $ 691,321 $ 777,552 $ 656,902
Service        
Segment Reporting Information        
Revenue $ 45,000      
v3.23.2
Segment and Geographic information - Revenue by Geographical Segment (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Segment Reporting Information      
Revenue $ 691,321 $ 777,552 $ 656,902
Hong Kong      
Segment Reporting Information      
Revenue 561,855 630,238 537,553
China      
Segment Reporting Information      
Revenue 84,546 120,978 107,325
South Korea      
Segment Reporting Information      
Revenue 9,168 11,802 5,497
United States      
Segment Reporting Information      
Revenue 19,744 12,470 5,492
Other countries      
Segment Reporting Information      
Revenue $ 16,008 $ 2,064 $ 1,035
v3.23.2
Segment and Geographic information - Revenue by Product Type (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Segment Reporting Information      
Revenue $ 691,321 $ 777,552 $ 656,902
Power discrete      
Segment Reporting Information      
Revenue 458,795 545,135 482,718
Power IC      
Segment Reporting Information      
Revenue 218,620 220,882 161,726
Packaging and testing services      
Segment Reporting Information      
Revenue 3,979 11,535 12,458
License and development services      
Segment Reporting Information      
Revenue $ 9,927 $ 0 $ 0
v3.23.2
Segment and Geographic information Location and Net Book Value of Long-Lived Assets (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Jun. 30, 2022
Revenues from External Customers and Long-Lived Assets [Line Items]    
PPE and land use rights $ 382,180 $ 342,340
China    
Revenues from External Customers and Long-Lived Assets [Line Items]    
PPE and land use rights 114,822 105,326
United States    
Revenues from External Customers and Long-Lived Assets [Line Items]    
PPE and land use rights 263,083 232,731
Other countries    
Revenues from External Customers and Long-Lived Assets [Line Items]    
PPE and land use rights $ 4,275 $ 4,283
v3.23.2
Restricted Net Assets (Details) - China - Subsidiaries [Member] - USD ($)
$ in Millions
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Restricted Statutory Reserves [Line Items]    
Foreign subsidiaries, restricted statutory reserves $ 93.2 $ 92.4
Foreign subsidiaries, restricted statutory reserves percent of parent consolidated net assets 10.50% 10.80%
Minimum    
Restricted Statutory Reserves [Line Items]    
Foreign subsidiaries, minimum percent of after-tax profit required annually in statutory reserves 10.00%  
Maximum    
Restricted Statutory Reserves [Line Items]    
Foreign subsidiaries, statutory reserves maximum cumulative amount as a percent of registered capital 50.00%  
v3.23.2
Commitments and Contingencies - Purchase Commitments (Details) - USD ($)
$ in Millions
Jun. 30, 2023
Jun. 30, 2022
Raw materials, wafers, and packaging and testing services purchase commitments [Member]    
Purchase Commitment, Excluding Long-term Committment [Line Items]    
Purchase commitment, amount $ 127.5 $ 89.9
Property and equipment purchase commitments [Member]    
Purchase Commitment, Excluding Long-term Committment [Line Items]    
Purchase commitment, amount $ 9.7 $ 63.4
v3.23.2
Commitments and Contingencies - Contingencies and Indemnities (Details) - USD ($)
Jun. 30, 2023
Jun. 30, 2022
Indemnification Agreement    
Loss Contingencies [Line Items]    
Indemnification accrual $ 0 $ 0
v3.23.2
Schedule II - Valuation and Qualifying Accounts (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
SEC Schedule, 12-09, Allowance, Credit Loss      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance $ 30 $ 30 $ 30
Additions 0 0 0
Reductions 0 0 0
Balance 30 30 30
Allowance for Price Adjustments      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance 18,731 12,415 30,092
Additions 165,543 170,651 178,902
Reductions (144,298) (164,335) (196,579)
Balance 39,976 18,731 12,415
SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance 5,755 41,474 37,827
Additions 931 0 3,647
Reductions 0 (35,719) 0
Balance $ 6,686 $ 5,755 $ 41,474